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Abstract 
 
 Injury, infection and tissue malfunction are triggers of inflammation which if 
not regulated may acquire new characteristics that result in pathological outcomes.  
Since innate immunity plays a key role in the resolution of acute inflammation 
knowledge of the regulation of this component of the host response is relevant to 
understanding processes in disease progression and therefore has potential clinical 
benefits. 
 In this thesis I have applied zebrafish as a model organism to investigate the 
response of innate immune cells to qualitatively distinct inflammatory signals in the 
absence of adaptive immunity. Using a zebrafish embryo wound injury model I have 
investigated leukocyte migration profiles by in vivo imaging. In response to wound 
alone leukocytes migrated to the site of injury with predominantly random walk 
behaviour. However, the addition of lipopolysaccharide (LPS) enhanced recruitment 
and influenced the directionality of leukocyte migration to the wound. I demonstrate 
that leukocyte dynamic behaviour is also dependent on the location of the cells. The 
LPS enhanced directionality and reduced the random walk behaviour of the 
leukocytes, and these effects were ablated in the presence of the p38 mitogen-
activated protein kinase (MAPK) specific inhibitor SB203580.  
 Cytokine gene profiling in adult zebrafish leukocytes reveals that LPS can 
stimulate a pro-inflammatory response via the activation of p38 MAPK characteristic 
of mammalian innate immune responses. 
 It is documented in mammalian innate immune cells that LPS can modulate 
Notch mediated signalling and thereby cell function. Using zebrafish with null 
mutations in Notch, which provide an unbiased in vivo model, I have investigated the 
influence of Notch signalling on leukocyte recruitment and demonstrate that 
migration to a wound injury is reduced.  However, this effect is due to decreased cell 
numbers and not altered function as the Notch signalling inhibitor DAPT had no 
effect of recruitment to wound injury. The defect in myelomonocyte numbers was 
also present in adult zebrafish and this was partially compensated for by an increase 
in lymphocytes. 
 The experimental results that I report here highlight zebrafish as a model 
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organism for studying the function and regulation of innate immunity. The unique 
optical translucency, which permits in vivo imaging of host responses in real-time, 
facilitates the analysis of the innate immune response to different inflammatory 
signals and immune modulators.  
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BD., Lamb, JR.,  Dallman, MJ. (Under review). "Notch defects impair 
myelomonocyte development in zebrafish." Blood. 
 Controversy persists regarding the role of Notch in myelopoiesis. Previous 
studies have employed over-expression or loss of function approaches in 
selected cell lineages. Here we report an unbiased analysis which used two 
Notch zebrafish mutants beamter (BEA) and deadly seven (DES), with 
disrupted function in deltaC and notch1a respectively, to analyse leukocyte 
populations during development and in adults. We found that both BEA and 
DES adult fish had a decreased proportion of myelomonocytes in both the 
hematopoietic organ (kidney marrow) and the periphery (coelomic cavity), 
which was accompanied by an increased proportion of lymphocytes. The 
myeloid compartment was also affected in the mutant embryos as reflected 
by lower numbers of granulocytic cells migrating to a wound site. However 
notch1a mutation did not affect their survival following infection with 
Mycobacterium marinum. Together these results indicate that defects in 
Notch signalling alter myelopoiesis from the early stages of development. 
 
Taylor, H., Liepe, J., Bugeon, L., Huvet, M., Shia, A., Brown, S., Lamb, JR., Stumpf, 
MPH., Dallman, MJ. (Submitted). "In-vivo single cell tracking in zebrafish and 
statistical modelling reveal heterogeneity in recruitment and chemotactic behaviour 
in leukocytes." J R Soc Interface. 
 Migration of leukocytes is an important component of the complex 
inflammatory response to local injury and infection, but the mechanisms of 
recruitment remain incompletely understood. In this study we use automated 
computer tracking of single cells in an optically transparent model organism 
(zebrafish embryo) which provides an unbiased, in vivo, platform for the 
real-time analysis of leukocyte migration. Using this approach, which 
increases statistical power in comparison to previous studies, we demonstrate 
that LPS enhances the recruitment of leukocytes to a wound site. Importantly, 
LPS influences the directionality, but not the speed of movement of 
leukocytes in response to wound injury in a p38 mitogen-activated kinase 
(MAPK)-dependent fashion. We further demonstrate, we believe for the first 
time in vivo, that leukocyte dynamic behaviour is dependent on the location 
of cells with respect to blood vessels and the wound site. In particular, 
random walk-like behaviour is seen to predominate in the proximity of, as 
well as far away from the site of wound injury, while at intermediate 
distances, directed migration towards the wound site becomes predominant. 
This platform offers the opportunity to evaluate the efficacy of candidate 
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CHAPTER 1. Introduction 
 
Innate immunity and Inflammation 
 
Inflammation can be regarded as a physiological process that maintains 
homeostasis in response to stress, damage or infection of tissues (Medzhitov, 2008). 
The inflammatory pathway can be considered to be made up of four components; the 
inducers, the sensors, the mediators and the effectors of inflammation (Medzhitov, 
2008). The inflammatory pathway is tightly regulated. If this tight regulation fails 
inflammatory programs instead of facilitating homeostasis can cause tissue damage 
and disease.  
 
Inducers and sensors of inflammation 
 
The inducers of inflammation are the signals that initiate a response and can be 
categorised as endogenous or exogenous in origin. Exogenous signals are divided 
into two classes, microbial and non-microbial. Microbial inducers include pathogen-
associated molecular patterns (PAMPs) and virulence factors, specialised sensors 
detect the activities of virulence factors. Non-microbial exogenous inducers include 
allergens, irritants, foreign bodies and toxic compounds (Medzhitov, 2008). Stressed 
or malfunctioning tissues within the body produce endogenous inducers of 
inflammation. Desquestration, the release of cells or molecules that under basal 
conditions are contained within cellular of tissue membranes, alerts inflammatory 
sensors to tissue damage that results in the release of inflammatory mediators. 
Exogenous microbial inducers of inflammation can be divided into two classes. 
The first class is the PAMPs that are diverse microbial products including 
lipopolysaccharide (LPS), peptidoglycan, double stranded RNA and single stranded 
RNA (reviewed in Janeway and Medzhitov, 2002). These PAMPs are sensed by 
dedicated receptors, pathogen recognition receptors (PRRs) including the Toll-like 
receptors (TLRs) and Nod (nucleotide-binding oligomerization domain)-like 
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receptors (NLRs), that are responsible for mobilization and activation of immune 
cells which respond by attempting to remove the microbial threat and return the 
invaded tissue to homeostasis ( reviewed in Beutler et al., 2003). Toll receptors were 
first identified in Drosophila melanogaster in which they were found to be important 
for antifungal defence. Subsequently a homologous family of Toll receptors was 
identified in mammals (Medzhitov et al., 1997). Many TLRs span the membranes of 
host innate immune cells sensing microbial inducers and initiating downstream 
signaling that results in the production of many inflammatory mediators including 
cytokines, chemokines, and prostaglandins (Anderson, 2000, Beutler et al., 2003, 
Medzhitov, 2008). The NLRs are intracellular receptors that also recognise bacterial 
PAMPs. While the TLRs were initially identified in Drosophila plants were the 
model system in which cytosolic sensing proteins were first identified (Philpott et al., 
2000, Chisholm et al., 2006). These discoveries later led to the identification of the 
NLRs including the Nod1 and Nod2 proteins (Girardin et al., 2001, Chamaillard et 
al., 2003). The second class of exogenous microbial inducer is the virulence factors 
that are derived from pathogens but not sensed by dedicated receptors. In the case of 
virulence factors it is the specific effects of the pathogen invasion on host tissues that 
result in the activation of the inflammatory response. For example pore forming 
exotoxins produced by bacteria result in the release of K
+
 ions that are sensed by the 
NALP3 inflammosome (Mariathasan et al., 2006).   
 
Mediators of inflammation 
 
The mediators of inflammation include vasoactive molecules, complement 
fragments, lipid mediators, inflammatory cytokines, chemokines and proteolytic 
enzymes (Edvinsson and Owman, 1975, Medzhitov, 2008). Mast cells and platelets 
release vasoactive amines including histamine and seratonin when they degranulate 
(Hersh and Bodey, 1970, Mekori and Metcalfe, 2000). These vasoactive amines have 
dilatory effects on blood vessels close to the site of inflammation and facilitate 
leukocyte recruitment (Edvinsson and Owman, 1975, Medzhitov, 2008).  
Lipid mediators of inflammation, including eicosanoids and platelet-
activating factors, have important roles in facilitating leukocyte activation and 
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recruitment (Kroegel et al., 1989). They are derived from the breakdown of 





to produce arachidonic acid and lysophosphatidic acid, which are 
the precursors for the two classes of lipid mediator, the eicosanoids and platelet-
activating factors. Arachidonic acid is processed via the cyclooxygenase (COX1 and 
COX2) or lipoxygenase pathways to produce prostaglandins and leukotrienes 
respectively. Prostaglandin production induces vasodilation whilst leukotrienes have 
a vasodilatory effect and a chemotactic effect on migrating leukocytes (Needleman et 
al., 1986). Cytokines, including IL-1, TNF! and IL-6, are produced by many cell 
types, most importantly macrophages, and mediate many inflammatory functions 
including activation of the endothelium and leukocytes (Mantovani et al., 1992, 
Cavaillon, 1994). Chemokines mediate the extravasation and chemotactic 
recruitment of leukocytes to sites of inflammation (Webb et al., 1993, Tanaka et al., 
1993, Medzhitov, 2008).  
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The classic leukocyte recruitment in response to tissue 
infection/injury/stress 
 
The immediate immunological response to tissue injury or infection is termed 
acute inflammation and as the most extreme manifestation of inflammation is the 
most well understood. Below is a schematic (Schematic 1) that illustrated the classic 
leukocyte recruitment response to tissue infection/injury/stress.  
 
 
Schematic 1. Schematic illustration of chemotactic recruitment of macrophages and 
neutrophils to a site of inflammation. Chemoattractants are released by stromal cells, and 
inflammatory targets (bacteria or dying cells). Schematic produced referencing Witko-
Sarsat et al., 2000 and Kindt et al., 2007.  
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Effectors of inflammation - leukocyte migration and function in 
inflammation  
 
Effectors of inflammation are the tissues and cells that respond to the 
mediators of inflammation as described below for the response to injury and 
infection. 
 
Innate immune cell types involved in inflammation in response to injury 
and infection   
 
Classically innate immune cell lineages have been defined by the 
combination of phenotype, namely cell surface markers and functional criteria. This 
method of classifying cell types has been challenged in recent years and it is now 
thought that the number of innate immune cell types we can define is only limited by 
the number of surface markers we use to classify them (Hume, 2006). Leukocytes 
show remarkable phenotypic and functional heterogeneity dependent on the different 
tissues they occupy (Gordon and Taylor, 2005) and plasticity in that changes in the 
microenvironment can modulate their phenotype. For example, in the presence of 
TLR mediated signalling and TGF" receptor I blockade type 2 (M2) macrophages 
are re-programmed to a type 1 (M1) phenotype.  Grouping cells involved in the 
immune response by function and cell surface phenotype has greatly increased our 
understanding of the biology of the immune response to injury and infection. Until 
we have much greater understanding of the complex inter and intra cellular networks 
that make up the immune system it is necessary entertain the concept of innate 




 The main functions of neutrophils at sites of inflammation are phagocytosis 
(Brewer, 1963), degranulation (Hirsch and Cohn, 1960, Hirsch, 1962) and killing of 
microorganisms (Brewer, 1972, Witko-Sarsat et al., 2000). They also mediate the 
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recruitment, activation and programming of antigen presenting cells (APCs) 
(Chertov et al., 1997, Bennouna et al., 2003, Nathan, 2006) and drive proliferation of 
T and B cells (Scapini et al., 2005, Ethuin et al., 2004). Although neutrophils secrete 
much lower levels of cytokines than mononuclear phagocytes they are often present 
in numbers orders of magnitude higher than mononuclear phagocytes and so are 
important producers of activating cytokines (Nathan, 2006). Whilst macrophages can 
be tissue resident, namely they are present in tissues that are in homeostasis, 
neutrophils will only exit the blood stream and enter tissues that are stressed.  
 
Neutrophil recruitment to sites of inflammation 
 
Neutrophils have both anti-infectious and pro-inflammatory roles and are the 
first leukocytes to cross the endothelium and migrate to the site of inflammation. The 
rapid response of neutrophils to inflammatory stimuli requires the ability to migrate 
rapidly across the endothelium and move from circulating blood cells to specific sites 
of inflammation. This rapid response is initiated by the appearance of new adhesion 
molecules on the endothelium closest to the inflamed site. These adhesive molecules 
cause the neutrophil to associate with the endothelium and in combination with the 
shear force produced by the blood flow results in “rolling” of the neutrophil along 
the endothelium (Atherton and Born, 1972). The first of these adhesion molecules to 
be identified was L-selectin (leukocyte-selectin, expressed on neutrophils, monocytes 
and lymphocytes) (Gallatin et al., 1983, Bevilacqua and Nelson, 1993), and 
subsequently P-selectin (platelet-selectin, expressed on platelets and endothelial 
cells) and E-selectin (endothelial-selectin, expressed on endothelial cells) were 
identified (Hsu-Lin et al., 1984, Bevilacqua et al., 1987). L-selectin binds to ligands 
on some epithelial cells and E and P-selectins bind to ligands on most leukocytes 
(McEver and Cummings, 1997). The lectin domains of selectins interact with 
specific glycoconjugate ligands, mainly mucins, and these interactions mediate the 
rolling of the neutrophil along the endothelium (McEver et al., 1995). Integrins of 
the "2 sub-family are expressed on neutrophils and interact with Inter-Cellular 
Adhesion Molecule 1 (ICAM-1) molecules on the endothelial cells; these 
interactions are stronger than those of lectins and their ligands (Sligh et al., 1993, 
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Muller, 2003). These Integrin/ICAM-1 adhesion interactions eventually become 
strong enough so that the neutrophil ceases to roll along the endothelium and adheres 
completely to the surface, this is called arrest or adhesion. Neutrophils require 
activation by agonists including, platelet-activating factor (PAF), interleukin 8 (IL-
8), Formyl-Methionyl-Leucyl-Phenylalanine (fMLP), tumour necrosis factor alpha 
(TNF!) and Complement component 5a (C5a), before "2 integrins are able to 
interact with their ligands (Witko-Sarsat et al., 2000). Cytokine activated endothelial 
cells can transport neutrophil activating chemokines, for example IL-8, from their 
abluminal surfaces and by internalisation and transcytose the chemokines to the 
luminal surface (Middleton et al., 1997). 
Transmigration of neutrophils across the endothelium can occur via the para-
cellular or trans-cellular route. Para-cellular transmigration is the migration of 
leukocytes from the luminal side of capillaries through endothelial-cell junctions to 
the abluminal side. Endothelial transmembrane junctional molecules, for example 
PECAM-1, participate in para-cellular transmigration (Newman, 1997, Vestweber, 
2002). Until recently it was thought that para-cellular transmigration was the sole 
mechanism of neutrophil endothelial extravasation. However trans-celllular 
neutrophillic migration has been shown to occur (Feng et al., 1998) and whilst it is 
the route of extravasation for only a minority of cells (Carman and Springer, 2004) it 
can be very rapid (Cinamon et al., 2004).  
 
Neutrophils as effectors of inflammation 
 
Like macrophages neutrophils are phagocytes. Two classes of receptor 
expressed on the neutrophil cell surface are responsible for initiation of phagocytosis. 
These are the Fc# receptors and the complement receptors. The downstream 
signalling processes that mediate phagocytosis are different for each class of 
receptor. Fc# receptor promoted phagocytosis involves activation of PI3-kinase and 
Rho proteins and subsequently the formation of the phagocytic cup that eventually 
engulfs the target particle (Caron and Hall, 1998, Witko-Sarsat et al., 2000). PI3-
kinase is required for the final myosin-induced closure of phagosomes to complete 
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engulfment of particles (Swanson et al., 1999). There is cooperation between 
complement receptors, CR1 and CR3, and Fc# receptors as demonstrated by 
neutrophils from CR3 deficient patients which have impaired antibody dependent 
phagocytosis (Dana et al., 1984).  
Neutrophils contain granules that enclose anti-microbial molecules that are 
released when neutrophils come into contact with pathogens, this process is called 
degranulation (e.g. Spitznagel, 1990, Elsbach, 1998, Lehrer and Ganz, 1999, Nathan, 
2006). Enzymes within neutrophil granules, including NADPH-dependent oxidase 
and MPO, contribute to the production of anti-microbial molecules such as reactive 
oxygen species (ROS) and hydrogen peroxide (H2O2). As well as anti-microbial 
small molecules neutrophil granules contain many anti-microbial peptides and 
proteins reviewed by Lehrer and Ganz (1999). Neutrophils, once thought to be 
relatively transcriptionally inactive, have recently been shown to be important 
producers of inflammatory cytokines (Witko-Sarsat et al., 2000, Nathan, 2006). The 
anti-microbial molecules released from neutrophil granules can be indiscriminately 
damaging to host tissue as well as microorganisms (Henson and Johnston, 1987). 
The release of these non-specific molecules on degranulation by neutrophils can 
result in tissue damage and ultimately disease (Weiss, 1989). Below is a schematic 
that illustrates the types of granules found within neutrophils and the anti-
microbial/tissue damaging molecules and proteins that they contain (Schematic 2).  
 





Schematic 2. Neutrophil effector mechanisms involved in the defence against 
pathogens and in the inflammatory process. Neutrophil effector systems are mobilized 
following phagocytosis of a pathogen. Complement opsonins C3b and C4b are 
recognized by CR1 and CR3. IgG opsonins are recognized via the immunoglobulin 
receptors (FcgammaR). The first microbicidal pathway is the oxidative response, which 
complex activation, including superoxide anion (O2 -), hydrogen peroxide (H2O2), and, 
via myeloperoxidase, hypochlorous acid (HOCl) and chloramines. The second 
microbicidal pathway is non-oxygen–dependent and consists of the release in the 
phagolysosome or in the extracellular medium of preformed proteins stored in granules. 
Serine proteases, antibiotic proteins, as well as myeloperoxidase are contained in 
azurophilic granules. Metalloproteinases (collagenase and gelatinase) and antimicrobial 
proteins (lactoferrin and cathelicidin) are contained in specific granules. Gelatinase is also 
contained in tertiary granules, also called gelatinase granules. This figure and legend are 




The classical definition of a mononuclear phagocyte is a cell that has stellate 
morphology, displays evidence of endocytosis, expresses certain enzymes detectable 
by histochemical staining (e.g. lysosomal hydrolases) and performs non-specific and 
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specific uptake of particles (Hume, 2006). Macrophages make up a large component 
of the mononuclear phagocyte system. They are derived from progenitors in the bone 
marrow which develop into circulating monocytes that do not proliferate during 
steady state conditions but have the capacity to enter tissues following inflammatory 
stimuli and mature into macrophages (van Furth and Cohn, 1968). Whilst monocytes 
respond to signals and migrate to sites of inflammation, tissue resident macrophages 
are present throughout the tissues of organs in times of homeostasis and sense 
changes in homeostatic processes (Laskin et al., 2001). The propensity for a 
monocyte to migrate towards inflammatory lesions, or to enter normal tissues, can be 
predicted by the heterogenic expression of certain cell markers. Geissman et al. 
identified combinations of mouse monocyte surface markers that corresponded to 
heterologous surface markers on human monocytes, and these findings indicated it 
would be possible to study the in vivo relevance of monocyte heterogeneity 
(Geissmann et al., 2003). The large number of stimuli reported to activate 
macrophages, and the variation in transcriptional responses of macrophages to 
additive/combinatorial stimuli demonstrates the phenotypic plasticity of this cell type 
(Hume et al., 2002). The phenotypic plasticity of macrophages means they can adopt 
different functional roles within the tissue depending on the environmental stimuli 
they experience (Gordon and Taylor, 2005). 
 
Macrophages as effectors of inflammation 
 
Monocytes are recruited to sites of inflammation from the blood stream in a 
similar way to neutrophils. Neutrophils are the first leukocyte to migrate across the 
epithelium in response to inflammation and are active in recruiting other cell types 
including monocytes that, after several hours, cross the endothelium and enter the 
inflamed tissue where they differentiate into inflammatory macrophages. This later 
recruitment of monocytes is regulated by expression of monocyte selective adhesion 
molecules by the endothelium, for example Vascular Cell Adhesion Molecule-1 
(VCAM-1), which is expressed later compared to the neutrophil adhesion molecules 
(Chan et al., 2001).  
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At the site of inflammation macrophages are directed by the mediators of 
inflammation and respond to varied environmental signals by changing phenotype 
and function. In some circumstances environmental signals will result in enhanced 
antimicrobial activity and increased immune function. However some environmental 
cues can result in macrophages that are more susceptible to pathogenic infections and 
less able to produce inflammatory cytokines (Mosser and Edwards, 2008). 
Macrophages are responsible for the clearance of general cellular debris produced 
when tissues undergo remodelling, and the phagocytosis of cells that have undergone 
apoptosis. In general these tasks do not activate the macrophage and do not induce 
the production of inflammatory mediators, in fact the macrophage’s principal role 
can be considered to be that of house keeping by maintaining homeostasis within 
tissues, which it carries out independent of other immune cells (Mosser and Edwards, 
2008). However tissue damage that results in the cell death by necrosis rather that 
apoptosis will activate the macrophages that clear the cell debris. For example the 
HMGB1 (high-mobility group box 1) is a protein usually restricted to the nucleus, 
however on necrotic cell death it is released into the extracellular matrix and acts as 
an endogenous mediator of inflammation and tissue damage (Tsung et al., 2005, 
Zhang and Mosser, 2008). Endogenous inflammatory signals activate the 
macrophage that then produces cytokines and other mediators of inflammation. The 
presence of microbes and their products and components will also activate the 
macrophage and induce the production of inflammatory mediators. The plasticity of 
macrophage phenotype and behaviour has resulted in attempts to classify the 
different types of activated macrophages based on the activating stimulus and the 
resulting effector function (Gordon, 2003, Mosser and Edwards, 2008). Macrophages 
were classed as M1 (classically activated) or M2 (alternatively activated) however 
this classification has recently been challenged and a new classification of 
macrophage activation based on three different homeostatic activities proposed 
(Mosser and Edwards, 2008). The three homeostatic functional groups proposed are: 
host defence (classically activated), wound healing and immune regulation 
(Schematic 3). Furthermore the three macrophage groups based on homeostatic 
functions are described as flexible with sliding scales of classification as 
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macrophages can evolve to share the characteristics of more than one group 
(Schematic 3).  
 
 
Schematic 3. The three populations of macrophages (proposed by Mosser and 
Edwards 2008) are arranged according to the three primary colours, with red designating 
classically activated macrophages, yellow designating wound-healing macrophages and 
blue designating regulatory macrophages. Secondary colours, such as green, may 
represent tumour-associated macrophages, which have many characteristics of regulatory 
macrophages but also share some characteristics of wound-healing macrophages. In obese 
individuals, wound-healing macrophages may transit towards a classically activated-
macrophage phenotype. Adapted from Mosser and Edwards 2008.  
 
Classically activated macrophages are defined as the effector macrophages 
that are produced during cell mediated immunity and are characterised by their 
activation by the inflammatory mediators IFN# and TNF! resulting in their enhanced 
microbicidal capacity and inflammatory cytokine production (Mackaness, 1977, 
Gordon and Taylor, 2005, Mosser and Edwards, 2008). Classically activated 
macrophages are required for efficient host defence of intracellular pathogens. 
Classical activation of macrophages can occur in response to innate and adaptive 
signals and results in complex intracellular signal transduction that activates 
transcription factors including NF-$B and the MAPKs (O'Shea and Murray, 2008).  
Defects in the IFN# signalling pathway results in increased susceptibility to bacterial 
and viral infections (Filipe-Santos et al., 2006). However the inflammatory 
mediators produced by classically activated macrophages are damaging to tissues 
and can result in immunopathology, for example rheumatoid arthritis (RA) 
(Szekanecz and Koch, 2007). 
Tissue-resident macrophages are often the first members of the immune 
system to be alerted to tissue stress or infection. Almost any noxious signal, or 
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deviation from homeostasis, within tissues will alert these tissue-resident 
macrophages and result in recruitment of first neutrophils and later more 
macrophages (Hume et al., 2002). Wound healing macrophages are tissue resident 
macrophages that are activated by IL-4, one of the first inflammatory mediators to be 
produced after tissue injury (Loke et al., 2007). IL-4 stimulates tissue resident 
macrophages to produce precursors of the components of the extracellular matrix and 
begin to contribute to tissue repair and healing (Gratchev et al., 2001, Kreider et al., 
2007). The primary source of IL-4 is thought to be from immune cells of the adaptive 
immune system (Mosser and Edwards, 2008). 
Like classically activated and wound-healing macrophages regulatory 
macrophages can be activated by innate or adaptive responses. Glucocorticoids 
released during stress responses have an inhibitory effect on macrophage 
inflammatory behaviour and result in a reduction in the production of inflammatory 
mediators and the generation of the regulatory macrophage phenotype (Sternberg, 
2006, Mosser and Edwards, 2008). Macrophage phagocytosis is not inhibited by 
glucocorticoid stimulation (Liu et al., 1999) in fact phagocytosis of apoptotic cells 
results in the production of TGF" which can contribute to the immunoregulatory 
function of macrophages (Fadok et al., 1998). The production of the anti-
inflammatory cytokine IL-10 is a characteristic of regulatory macrophages (Edwards 
et al., 2006). There is a requirement for two stimuli in order to generate regulatory 
macrophages. The first stimulus, for example ingestion of apoptotic neutrophils, 
prostaglandin stimulation or adenosine (Mosser and Edwards, 2008), combines with 
a second inflammatory stimulus, for example TLR signalling, resulting in the 
production of the most important characteristic of regulatory macrophages, the 
production of IL-10 (Edwards et al., 2006). Regulatory macrophages differ from 
wound healing macrophages in that they do not contribute to the production of 
extracellular matrix and they have higher levels of co-stimulatory molecules, for 
example CD80 and CD86, such that they can function as antigen presenting cells in 
T cell activation (Edwards et al., 2006, Mosser and Edwards, 2008). The plasticity of 
macrophages allow them to contribute to tissue remodelling, wound healing and host 
defence demonstrating the unequivocal requirement for macrophages to maintain 
homeostasis. 
 




There is controversy over the whether dendritic cells (DCs) constitute their 
own immune cell lineage or are a subset of the macrophage lineage separate from the 
mononuclear phagocyte system (e.g. Hume, 2006, Geissmann et al., 2010). This 
debate is ongoing and recently DCs were redefined as a subset of the macrophage 
lineage and have the primary role of antigen presentation and regulate the pathogen 
specific adaptive immune response (Hume, 2008). They were first described in the 
1970s as a large stellate cell with properties distinct from mononuclear phagocyte 
cell types (Steinman and Cohn, 1973). DCs process proteins to produce peptides that 
are presented to T cells via major histocompatibility complexes (MHC) molecules 
(Itano and Jenkins, 2003). The surface markers that are used to distinguish 
macrophages from DCs in the lymphoid organs are expressed differently by 
macrophages and DCs when in other tissues (reviewed in Geissmann et al., 2010). 
Currently there is no specific single cell surface marker that designates a cell as a DC 
however they can be defined functionally by their ability to localize to the T cell 
zone of lymphoid organs where they stimulate T cells (Geissmann et al., 2010). 
 
Macrophages and neutrophils work in concert to combat microbial infection 
 
It is commonly thought that macrophages operate against intracellular 
pathogens whilst neutrophils operate against extracellular pathogens. Macrophages 
and neutrophils share a common origin and as such share functionalities including 
phagocytosis, kinetic behaviour, anti-microbial and immunomodulatory activity 
(reviewed in Silva, 2009). Macrophages and neutrophils work in concert at the site of 
infection to present a combined inflammatory response that attacks the invading 
pathogen and restores tissue homeostasis. Silva presented a comprehensive review of 
the data that supports macrophage/neutrophil collaboration in acute inflammation 
and this cooperation is summarised here in the schematic taken from his review 
(Schematic 4, (Silva, 2009).  
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Schematic 4. Schematic representation of the clustering and interactions of 
neutrophils, monocytes, and macrophages at inflammatory sites of infection by 
extracellular or intracellular pathogens. (Upper panel) Resident macrophages that detect 
the presence of invading pathogens (red rods) phagocytose them (A) and secrete 
chemokines, primarily recruiting neutrophils (such as CXCL8 and CXCL1/2/3; large red 
gradient) and monocytes (such as CCL2 and CCL3/4; large blue gradient). Recruited 
neutrophils become activated (B). Activated neutrophils complement the macrophage 
recruiting of inflammatory phagocytes by attracting additional inflammatory neutrophils 
(E) and monocytes (F) through the secretion of CXCL8 and CXCL1/2/3 (small red 
gradient) and CCL2 and CCL3/4 (small blue gradient), respectively. Recruited monocytes 
(C) give rise to inflammatory macrophages (D). (Lower panel) Infectious focus with 
resident macrophages clustered with recruited inflammatory neutrophils, monocytes, and 
macrophages (same cell styles as in upper panel). Effector mechanisms activated by 
phagocytes against invading pathogens (red rods) include: phagocytosis by resident (1) 
and inflammatory macrophages (2) and by recruited neutrophils (3); infected 
macrophages ingest neutrophils (4) and released neutrophil granule proteins (5) to 
enhance their antimicrobial capacity; activated neutrophils release granules and 
antimicrobial granule proteins that directly kill pathogens free in the extracellular space 
(6); neutrophil extracellular traps kill pathogens free in the extracellular space (7). This 
schematic and legend is from Silva (2009).   
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Mast cells 
 
Mast cells have important roles in innate and adaptive immunity and are 
important players in allergic inflammation. They sense inducers of inflammation 
through Fc receptors and can also be activated by complement components. In acute 
inflammation they release important inflammatory mediators including histamine, 
proteoglycans, proteases, leukotrienes, prostoglandins, cytokines and chemokines 
(e.g. Metcalfe et al., 1997, Prussin and Metcalfe, 2003)..   
 
The migration of immune cells through the interstitium 
 
 Much progress has been made in advancing our understanding of leukocyte 
activation and extravasation, however less is understood about the mechanics of 
leukocyte migration once they leave the blood stream and enter the tissues. After 
leukocytes go through the vascular basement membrane and enter the extravascular 
space they migrate along chemotactic gradients through the interstitium towards the 
site of inflammation. The interstitium is a three-dimentional environment constructed 
of a fibrillar network or densely packed cells. Leukocytes undergo amoeboid type 
movement consisting of fast reorganisation of cell shape to facilitate locomotion 
(Nourshargh et al., 2010). Movement of leukocytes within the interstitium is 
controlled by intracellular reorganisation of the actomyosin cytoskeleton. Leukocyte 
actin polymerisation is regulated by Rac proteins. Deletion of the RAC1 and RAC2 
proteins together in neutrophils or DCs results in rounded cells with no capacity for 
migration (Benvenuti et al., 2004, Sun et al., 2004, Nourshargh et al., 2010). The 
WASP family of proteins are involved in actin remodelling downstream of the Rac 
proteins (Snapper et al., 2005, Park et al., 2008). Myosin II is responsible for 
contractile pressures that propel matter forwards within the cell and also for 
detachment of the trailing edge of the cell to facilitate forward movement 
(Lammermann et al., 2008, Xu et al., 2003). A better understanding of the 
mechanisms of extravasation and extravascular migration will be beneficial for the 
identification of therapeutic molecular targets. For example increased knowledge of 
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the molecular mechanisms of leukocyte transendothelial and interstitial migration 
would allow more selective targeting of leukocyte migration in disorders including 
atherosclerosis, cancer and inflammatory disorders (reviewed in Nourshargh et al., 
2010). 
 Leukocytes in the interstitium respond to chemotactic gradients, which 
initiate signalling cascades resulting in chemotaxis. The effects of chemoattractants 
on neutrophil migration are mediated by many G-protein-coupled receptors 
(GPCRs). Signals including IL-8, C5a and fMLP are mediated by GPCRs and the 
resulting signalling stimulates the activation of a large number of intracellular 
signalling effectors including the Rho GTPases, Phosphoinositide 3-kinases (PI3Ks), 
and phospholipases (e.g. Xu et al., 2003, Stephens et al., 2008). The mechanisms by 
which the migrating cell senses the gradient of chemoattractant and implements a 
directional bias are not fully understood. It is now thought that sampling of the 
chemoattractant concentration occurs at the leading edge of the migrating cell at 
points of protrusion. One theory suggests that protrusions at the leading edge are 
created randomly in space and the protrusion that is exposed to the highest 
concentration of chemoattractant will be maintained over those exposed to lower 
concentrations resulting in biased movement up the gradient of signal (Arrieumerlou 
and Meyer, 2005, Stephens et al., 2008).  
 
Leukocyte recruitment to injury in the absence of infection 
 
The mechanisms underlying leukocyte recruitment to injury in the absence of 
infection, for example injuries induced by crushes and burns, are poorly understood 
when compared with the depth of knowledge regarding the acute inflammatory 
response to injury in the presence of infection. An elegant study has recently used 
models of sterile injury, namely major trauma in the absence of open wounds and 
damage to intestinal integrity, to show that mitochondrial danger-associated 
molecular patterns (DAMPs), are released into the circulation following sterile 
trauma (Zhang et al., 2010a). Mitochondria are endosymbionts originally derived 
from bacteria and consequently DAMPs bear bacterial molecular motifs. They are 
released following cell injury and activate human neutrophils through formyl peptide 
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receptor-1 and TLR9 leading to MAPK and the activation of signalling pathways 
usually associated with the sensing of bacterial PAMPs (Zhang et al., 2008). 
 
Acute and chronic inflammation and the resolution of 
inflammation 
 
The mediators of the resolution of inflammation 
 
 Resolution of inflammation, once thought to be a passive process, has now 
been shown to involve active biochemical programmes that return inflamed tissue to 
homeostasis (Serhan et al., 2008). Resolution of inflammation occurs when 
neutrophil recruitment to a site of inflammation ceases, macrophages clear apoptotic 
neutrophils, macrophages depart through the lymphatics and leukocyte cell numbers 
to return to pre-inflammation levels (Serhan and Savill, 2005). Mediators of the 
resolution of inflammation have anti-inflammatory and pro-resolutionary properties 
and include lipid mediators like the eicosanoids (e.g. lipoxins) (Levy et al., 2001), 
and newly identified chemical lipid mediators, the resolvins and protectins (Serhan et 
al., 2002). Resolution of inflammation is distinct from anti-inflammatory processes 
because pro-resolution mediators actively promote clearance of microorganisms and 
apoptotic cells (Serhan et al., 2008). So mediators of the resolution of inflammation 
are distinct from immunosuppressors of inflammation as they activate mechanisms 
that bring about the restoration of homeostasis in inflamed tissue. A few hours after 
entering the tissues neutrophils switch from releasing arachidonic acid derived 
prostaglandins and leukotrienes to the pro-resolutionary arachidonic acid derived 
lipoxins, and so the initiators and terminators of inflammation have common origins 
(Serhan and Savill, 2005). It has also now been shown that lipid resolution mediators 
of resolution are derived from omega-3 polyunsaturated fatty acids precursors 
including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Serhan et 
al., 2002). Lipoxins are lipoxygenase-derived eicosanoids and mediate the inhibition 
of neutrophil entry to the tissues via chemotaxis and adhesion, as well as the uptake 
of apoptotic neutrophils at sites of inflamed tissue by macrophages (Godson et al., 
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2000). Neutrophils from resolving inflammatory exudates switch from producing 
pro-inflammatory leukotrienes to resolving molecules like lipoxins and resolvins 
(Levy et al., 2001). Resolvins were first identified from murine dorsal air pouch 
exudates in the spontaneous resolution phase (Serhan et al., 2000). The resolution of 
inflammation is now considered to be a regulated and integral component of the 
acute inflammatory response and its dysregulation can lead to chronic inflammation 




Failure to resolve acute inflammation and return tissues to homeostasis 
results in chronic inflammation and disease. Chronic inflammation occurs when 
there is a failure to resolve inflammation induced by pathogens or endogenous 
signals and is characterised by the accumulation of activated macrophages. There are 
many chronic inflammatory disorders which effect many tissue and organs and 
include chronic obstructive pulmonary disease (COPD), atherosclerosis, psoriasis, 
inflammatory bowel disease (IBD), and RA. RA is a classic inflammatory disease 
and I will use this disease to illustrate the characteristics of chronic inflammation. 
RA is thought to be initiated by an unknown stimulus that instigates local 
inflammation, although due to its MHC class II association is likely to involve 
antigen recognition and T cell activation. This local inflammation activates cells in 
the synovial lining resulting in the recruitment of immune cells to the joint, which 
under normal conditions would have no immune cells. In RA leukocytes including 
neutrophils, macrophages, B-cells and T-cells are present in the joint (e.g. Wong and 
Lord, 2004). Cytokines including TNF! and IFN# contribute to the immune 
processes that result in the pathology of chronic inflammatory conditions including 
RA. TNF! is crucial to the pathology of RA and it is now the standard target in the 
treatment of patients with RA (McInnes and Schett, 2007). Anti-TNF! antibodies 
and IL-1 receptor agonists are strategies for the treatment of RA. However whilst 
these treatments do ameliorate the symptoms of RA they do not eliminate the disease 
(Wong and Lord, 2004). B cells produce autoreactive antibodies and contribute to the 
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recruitment of other leukocytes including neutrophils (Silverman and Carson, 2003). 
T cells are proposed as the drivers of inflammation in RA by cellular interactions, 
cytokine production and their interaction with and activation of macrophages (e.g. 
Brennan et al., 2002, Wong and Lord, 2004). Macrophages in the synovial 
membrane are activated demonstrated by their production of cytokines and over 
expression of MHC molecules and the number of macrophages strongly correlates 
with joint damage in patients with RA (Kinne et al., 2000, Wong and Lord, 2004). 
Neutrophils are found in an activated state the synovial fluid of RA patients where 
they produce IL-8, complement C5a and leukotriene B4 (Lopez et al., 1995, Wong 
and Lord, 2004). Neutrophil apoptosis is inhibited in the synovial fluid and this 
results in increases in joint damaging neutrophil derived proteinases, hydrolases and 
ROS (Wong and Lord, 2004). The complex nature of the factors involved in disease 
pathogenesis in RA and the absence of the understanding of the underlying causes of 
RA mean that, whilst treatments are available that can relieve the symptoms, so far 




Chronic inflammation arising from pathogenic or physiological induced 
tissue damage can result in fibrosis which can occur in many different organs, 
including lung, kidney and liver, and results in pathology (Cohen, 1995, Ward and 
Hunninghake, 1998, Kershenobich Stalnikowitz and Weissbrod, 2003). Fibrotic 
pathology is characterised by activation of fibroblasts and the accumulation of 
collagenous extracellular matrix (ECM) (Raghow, 1994, Johnson, 1996, Nakatsuji et 
al., 1998, Sivakumar and Das, 2008). Fibrotic diseases are difficult to treat and 




Recently the concept of para-inflammation has been introduced and occurs in 
tissues that have not incurred any direct injury or infection but rather a malfunction 
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or stress to the tissue requires physiological action in order to restore the tissue to a 
homeostatic state. The tissue -resident macrophages are the first cells that sense the 
stress or malfunction and if the changes are considerable they recruit additional 
macrophages and other leukocyte cell types. This inflammatory response in the 
absence of injury or infection is termed para-inflammation as it is considered a state 
between the basal and traditional inflammatory state. If inflammatory responses do 
not return the stressed/malfunctioning tissue to homeostasis para-inflammation can 
become chronic inflammation (Medzhitov, 2008).  
 
The role of the adaptive immunity in resolution of inflammation and 
infection 
  
The main focus of this literature review has been to outline the nature of 
inflammation in the context of innate immunity as this component of the host 
response relates directly the scientific aims of my thesis project. However adaptive 
immunity also plays a central role in restoring tissue homeostasis following 
inflammation.  The innate immune system can be defined as “all aspects of the host's 
immune defence mechanisms that are encoded in their mature functional forms by 
the germline genes of the host” (Chaplin, 2010). The adaptive immune response 
involves tightly regulated interactions between APCs and T and B cells that  
“facilitates pathogen-specific immunologic effector pathways, generation of 
immunologic memory, and regulation of host immune homeostasis” (Bonilla and 
Oettgen, 2010). Where the innate immune system recognises pre-programmed 
patterns the molecules of the adaptive immune system are more specialised and 
recognise specific antigens and epitopes. The adaptive immune system has evolved 
in response to the ability of pathogens to mutate and avoid host detection (Pancer and 
Cooper, 2006). Through a process called somatic recombination, the rearrangement 
of the immunoglobulin V, D and J gene fragments, receptors are custom made and 
this diversity means that there is no limit to the number of pathogen components the 
immune system can recognise (reviewed in Bonilla and Oettgen, 2010). In addition 
to antigen specificity and altered kinetics of response, namely primary versus 
secondary immune responses, memory is a key feature which distinguishes adaptive 
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and innate immunity.  Reviewing the contribution of adaptive immune responses in 
inflammation is beyond the scope of this study which focuses on the role of the 
innate immune system in inflammatory processes.  
 
p38 MAPK as a mediator of inflammation 
 
MAPKs belong to a family of highly conserved serine/threonine protein 
kinases of which there are three main classes, the extracellular signal-regulated 
kinases (ERKs), the c-jun N-terminal kinase (JNK) and the p38 MAPKs. The 
signalling cascade that activates all MAPK is conserved from yeast to mammals 
(Johnson and Lapadat, 2002). Of the three main classes of MAPK p38 is considered 
to be the most promising therapeutic target for inflammatory diseases.  
 p38 MAPK has multiple roles in the intracellular regulation of many cellular 
responses to stress stimuli. As well as having important, and well characterised, roles 
in the regulation of apoptosis, cell-cycle, tumorogenesis and cell differentiation, p38 
MAPK plays a central role in the regulation of cellular responses to inflammatory 
signals and is a key mediator of inflammatory processes. For this reason p38 MAPK 
has become an important target in the search for therapeutic drugs to treat 
inflammatory disorders, for example asthma (Adcock et al., 2008), RA (Thalhamer 
et al., 2008) and atherosclerosis (Osman et al., 2008). p38 MAPK is an intracellular 
component of complex inflammatory signal transduction pathways (Lee and Young, 































Schematic 5. Schematic of the p38 MAPK signal transduction network produced by 
Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al., 2010)
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p38 MAPK regulates the production of important inflammatory mediators 
and was first identified as a MAP kinase which could be targeted by LPS and 
hyperosmolarity (Han et al., 1994). Later that year p38 MAPK was identified 
again in a pharmacological screen for compounds that modulate the production 
of inflammatory mediator TNF! (Lee et al., 1994). Four isoforms of p38 MAPK 
have been identified (!, ", # & %) which each have more that 60% sequence 
homology overall however have differences in their tissue expression, upstream 
activators and downstream targets (Coulthard et al., 2009). The p38 MAPK 
subfamily can be divided into two subsets, one subset p38! and p38" and the 
other p38# & p38%. These subsets are based on their amino-acid sequence 
identity and their capacity to be inhibited by low concentrations of the inhibitor 
SB203580. p38! and p38" are inhibited at low concentration of SB203580 
whilst p38# & p38% are not (Kumar et al., 1997). SB203580 inhibits ATP 
binding in the ATP binding pocket when a fluorine atom present on the drug 
interacts with Thr106 in the hinge of the binding pocket and the subsequent 
orientation of the drug in the pocket prevents ATP binding (Gum et al., 1998). 
The duration and magnitude of the activation of p38 MAPK is transient. 
Activation occurs within minutes of the stimulation signal and is quickly 
downregulated by protein phosphatases. These include PP2C (Ser/Thr 
phosphatase) and PTP (Tyr phosphatase) (Takekawa et al., 1998, Takekawa et 
al., 2000). The M3/6 and MKP phosphatases have also been shown to regulate 
p38 MAPK activation (Keyse, 2000, Tanoue and Nishida, 2003, Liu et al., 
2007).  
Inhibitors of p38 MAPK block the production of TNF!, IL-1, IL-8 and 
COX2 by monocytes (Lee et al., 1994, Westra et al., 2004). p38 can also 
regulate TNF! and IL-1 at the transcriptional and translational levels (Lee et al., 
1994, Campbell et al., 2004, Baldassare et al., 1999). In mice that lack the p38 
direct downstream target MAPK-activated protein kinase 2 (MAPKAP-K2) 
there is a defect in TNF! and IL-6 cytokine production on stimulation with LPS 
(Kotlyarov et al., 1999). The p38! isoform is thought to be responsible for 
cytokine production as mice lacking the p38" isoform, which is the isoform 
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most closely related to p38!, have no defects in cytokine production 
(Beardmore et al., 2005). p38 MAPK regulates post translational gene 
expression by regulating the stability of mRNAs encoding many inflammatory 
mediators including TNF!, IL-1, IL-6, COX-2 and many more (Clark et al., 
2003). Inflammatory transcriptional targets of p38 MAPK in the context of a rat 
model of RA are illustrated in Table 1.  
 
Table 1. Gene expression profiles of rat fibroblast-like synoviocytes upregulated by 
TNF-! and inhibited by SB-203580. Table taken from Zer et al., 2007. 
 
  The role of p38 MAPK as a regulator of inflammatory responses extends to 
the TLR4 receptor-signalling pathway, where it has been shown to be selectively 
required for TRAF6-ASK1 dependent TLR4-mediated innate immunity (Matsuzawa 
et al., 2005). p38 MAPK is also required for phosphorylation and phosphoacetylation 
of histone H3 selectively occurring on the promoters of cytokine and chemokine 
genes, enhancing the accessibility of NF-$B bnding sites, in response to LPS and 
other TLR ligand stimulation (Saccani et al., 2002, Ghosh and Hayden, 2008).  
p38 MAPK as well as regulating production of inflammatory mediators 
regulates the effector function of leukocytes by controlling their migration in 
response to inflammatory stimuli (Cara et al., 2001, Aomatsu et al., 2008). p38!, but 
no other p38 isoform, has been shown to be required for the transduction of 
chemotactic signals involved in cell migration (Rousseau et al., 2006). N-formyl-L-
 
   35 
leucyl- L-phenylalanine (fMLP) and C5a induced neutrophil chemotaxis requires the 
relay of chemotactic signals by p38 (Heit et al., 2002, Heuertz et al., 1999). 
 
Inhibitors of p38 MAPK as anti-inflammatory therapeutic drugs 
 
Since inflammatory cytokines are known to cause and exacerbate 
inflammatory diseases, and p38 MAPK is a key regulator of the production of 
cytokines, inhibitors of p38 MAPK have been developed in order to test their 
efficacy as anti-inflammatory therapeutic drugs. Over the last decade there has been 
great optimism about the potential of p38 MAPK inhibitors as treatments for 
chronic-inflammatory disorders. However the recently published results of several 
clinical trials have proven disappointing and it is now considered the optimism 
surrounding the use of p38 MAPK inhibitors as treatments for inflammatory 
disorders is over (Goldstein et al., 2010). One inhibitor, AMG 548, reduced TNF! 
and IL-1" production by 85% in phase two clinical trials, however production was 
halted because it caused elevations in liver enzymes (Lee and Dominguez, 2005). 
Another clinical trial of the highly specific p38 inhibitor pamapimod was shown to 
be less effective at improving the Disease Activity Score in RA patients than existing 
treatments (Hill et al., 2008).  In a second phase 2 trial testing pamapimod in RA 
patients the outcome of treatment at the primary efficacy end point was similar in 
patients that received pamapimod and those that had received the placebo control 
(Alten et al., 2009). The development of pampimod has been discontinued on the 
basis of these phase 2 trials. Vertex (VX-745) is another p38 MAPK inhibitor that 
has been tested in phase 2 clinical trials for the relief of RA symptoms and is the 
drug that has produced the most encouraging results of any p38 MAPK inhibitor 
tested in phase 2 trials (Haddad, 2001). Although only limited information was 
disclosed subsequent reports detailed CNS toxicity in dogs treated with this 
compound. VX-702 is a modified version of the VX-745 compound that does not 
cross the blood brain barrier. When tested in clinical trials for the treatment of RA 
the efficacy of VX-745 was poor with little difference in outcome when compared 
with the placebo treatment. A second phase 2 study testing VX-745 had similar 
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results to the first. Neither of these studies demonstrated adverse liver or CNS effects 
(Damjanov et al., 2009). Another specific and highly potent orally administered 
small molecule p38! inhibitor is SCIO-469. This compound is the only p38 MAPK 
inhibitor that has been tested for analgesic efficacy. TNF! and IL-1 both contribute 
to and modulate acute and chronic pain. When SCIO-469 was used in trials to treat 
acute post-surgical dental pain patients that received SCIO-469 showed significantly 
longer times before they required rescue medication when compared with the 
patients that had received the placebo (Goldstein et al., 2010). SCIO-469 was also 
tested in phase 2 trials to treat RA however the response rate between SCIO-469 
treated patients and placebo did not reach statistical significance at the primary end 
point (Goldstein et al., 2010). The p38 inhibitor BIRB 796 was tested in a late stage 
clinical trial on patients with Crohn’s disease. However the outcome of this study 
revealed that there was no statistical difference in remission rates between BIRB 796 
treated and placebo treated patients (Schreiber et al., 2006). ARRY-797 is a p38 
inhibitor that has been reported to produce only a transient reduction in CRP in an 
RA clinical study, which is consistent with the transient reduction of CRP levels seen 
in other studies. The testing of ARRY-797 in inflammatory diseases has been 
discontinued and it is suggested that it will continue to be tested for analgesic effects 
(Goldstein et al., 2010). There are several other p38 inhibitor drugs being tested, 
mainly for their effect on neuropathic pain, however no clinical results of these 
studies have been released so far. The ability of p38 inhibition to block the synthesis 
of inflammatory cytokines resulted in the production of highly specific inhibitors of 
p38 MAPK. Despite the difficulty in producing specific inhibitors of kinases many 
highly specific inhibitors of p38 have been produced. Only very recently have the 
results of phase 2 clinical trials of these compounds been released, and a 
disappointing pattern of results has emerged. In the four RA trials and one Crohn’s 
disease trial that the results are known for it seems that whilst promising reductions 
in inflammatory biomarkers were observed early in the studies there was a 
compensatory mechanism after longer treatment with the p38 inhibitor. It remains to 
be elucidated whether inhibition of p38 in combination with other therapeutic 
strategies may yet result in the desired efficacy in treatment of inflammatory diseases 
(Goldstein et al., 2010).  
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Notch signalling  
 
Overview of Notch signalling 
 
 Notch/ligand interactions are important mediators of cell-cell communication 
and are involved in a wide range of biological processes including growth, survival, 
differentiation and proliferation (Artavanis-Tsakonas et al., 1999). Notch signalling 
is highly conserved across species. In 1917 fruit flies with notches in their wings 
were described (Morgan, 1917). These flies were later found to have loss of function 
in the Drosophila Notch gene, which was cloned in the 1980s (Wharton et al., 1985, 
Kidd et al., 1986). Mammals have four Notch receptors (Notch 1-4) and five Notch 
ligands (Delta-like1, 3, and 4 and Jagged 1 and 2) (reviewed in Radtke et al., 2010). 
A summary of Notch/ligand binding and signalling is outlined in Schematic 6.  
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Schematic 6. Notch receptors/ligands and signalling. A: Notch receptors and ligands. 
Vertebrates have four (Notch1 – 4). The extracellular domain of the receptors contain 
between 29 and 36 EGF-like repeats involved in ligand binding, followed by three 
cysteine-rich Notch/LIN12 (LIN) repeats. The LIN domain is followed by the 
heterodimerization domain (HD). The cytoplasmic part of the receptor contains two 
protein – protein interaction domains, the RAM (R) domain, six ankyrin repeats (ANK), 
two nuclear localization signals (NLS), a transcriptional transactivation domain (TAD) 
and a PEST sequence. The vertebrate Notch receptors can be activated by at least five 
ligands (Jagged1 and 2 (homologs of Serrate), and Delta1, 3 and 4 (homologs of Delta)). 
The common feature of these two ligand families is an N-terminal structure called DSL 
(Delta, Serrate and Lag). Both type of ligands contain EGF-like repeats in the 
extracellular domain, but only Serrate, Jagged1 and Jagged2 harbour an additional 
cysteine- rich (CR) sequence downstream of the EGF-like repeats. PM, plasmamembrane. 
B) Notch signalling. Notch receptors are synthesized as precursor proteins and cleaved in 
two during transport to the cell surface where they are expressed as heterodimers. Notch 
signalling is initiated by ligand binding which induces two subsequent proteolytic 
cleavages, the first mediated by TACE (tumor-necrosis factor a- converting enzyme) near 
the transmembrane domain, while the second cleavage which occurs within the 
transmembrane domain is mediated by the g-secretase activity of presenilins. The 
liberated cytoplasmic portion of the receptor (NIC) translocates to the nucleus and 
heterodimerizes with the transcription factor CSL. Binding of NIC to CSL leads to 
transcriptional activation by displacement of co-repressors (COR) and simultaneous 
recruitment of coactivators such as Mastermind-like proteins (MAML) that interact with 
P300. This schematic and legend are from Radtke 2005 (Radtke et al., 2005). 
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A crucial event in the Notch signalling cascade is the shedding of the 
ectodomain following ligand binding. This is mediated by proteases of the 
ADAM/TACE/Kuzbanian family, which regulate cleavage of the receptor resulting 
in release of the ectodomain (Brou et al., 2000, Mumm et al., 2000, Lieber et al., 
2002). The cleavage of the ectodomain results in the production of the membrane 
bound form of Notch which is called the Notch Extracellular Truncation (NEXT) 
(Schweisguth, 2004). NEXT is further cleaved at two sites by the activity of 
intracellular #-secretase, which is part of the Presenilin- Nicastrin-Aph1-Pen2 protein 
complex (Fortini, 2001, De Strooper, 2003). The cleavage of NEXT results in the 
release of the Notch intracellular domain (NICD) into the cytosol (Okochi et al., 
2002).  Notch signalling can occur via the canonical pathway, CSL dependent 
(known as CBF1 in humans, RBPJ in mouse and Suppressor of Hairless in flies) 
dependent, or non-canonical, CSL independent pathway (Martinez Arias et al., 
2002). In canonical signalling NICD translocates to the nucleus and forms a nuclear 
transcription complex with the DNA binding protein CSL and the Mastermind 
(Mam)/Lag-3 co-activator (known as MAML in humans) (Bray and Furriols, 2001, 
Petcherski and Kimble, 2000). The formation of this complex results in the 
transcription of Notch/CSL dependent genes (Schweisguth, 2004).  
Notch signalling feeds into the MAPK signalling pathway via the action of 
Ras, an upstream component of the MAPK signalling pathway illustrated in 
Schematic 7 (Alberola-Ila and Hernandez-Hoyos, 2003). Notch negatively regulates 
p38 activation by inducing the expression of MKP-1, a MAPK phosphatase, which 
directly inactivates p38. This MKP-1 induction is CSL dependent (Kondoh et al., 
2007). The degree of cross talk between the intracellular Notch and MAPK pathways 
is not clear and much work remains to be done to fully elucidate these interactions 
(Kondoh et al., 2007). 
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Schematic 7. Schematic of the Notch signalling produced by Kyoto Encyclopedia of 
Genes and Genomes (KEGG) (Kanehisa et al., 2010). 
 
Notch signalling and the immune system 
 
 Notch signalling is required for many cell fate decisions during 
embryogenesis and development. Notch1 and RBPJ are required for the development 
of embryonic HSCs in mouse (Kumano et al., 2003). Subsequently the role for Notch 
in HSC development was confirmed when it was shown that Jagged1, but not 
Jagged2, is required for generation of embryonic HSCs. This same study 
demonstrated that Jagged1/Notch signalling controlled Runx1 and GATA2 
expression, both are important mediators of haematopoiesis (Robert-Moreno et al., 
2008). Whilst Notch is required for haematopoiesis in the developing embryo the 
combined results of several studies indicate that canonical Notch signalling is 
dispensable for HSC homeostasis in the bone marrow (Radtke et al., 2010).  
            Notch1 signalling is required for the maturation of T cells (Radtke et al., 
1999, Han et al., 2002) However Notch1 does not simply function to instruct a 
bipotent progenitor cell to become a T cell as recent discoveries have demonstrated 
that loss of Notch function affects cell fates of myeloid cells and B cells as well as T 
cell development (Bell and Bhandoola, 2008, Feyerabend et al., 2009, Wada et al., 
2008). Notch2/Delta-like 1 (DLL1) signalling is involved in the specification of B 
cell subsets (Hozumi et al., 2004, Saito et al., 2003). DLL1 stimulation promotes the 
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development of DCs over other immune cell lineages including T cells and 
macrophages (Ohishi et al., 2001, Olivier et al., 2006).  
 Notch signalling extends beyond cell fate decisions in the developing 
immune system and plays a role in regulating the mature immune system. Notch1 is 
expressed in CD4+ T cells and the expression of Notch target gene hes1 is 
upregulated following activation (Benson et al., 2004). Notch ligand expression is 
also upregulated on T cells stimulated with inhibitory cytokines (Hoyne et al., 2001). 
Notch is a co-stimulatory molecule involved in the activation and effector functions 
of T cells (Benson et al., 2004). Notch is also proposed to have potential implications 
for the effector activity of B cells (Hoyne et al., 2001). Notch signalling is important 
for the regulation of T cell viability in vitro (Hoyne et al., 2001). It has recently been 
shown that Notch signalling is required for macrophage M2b polarisation in a murine 
lupus model via the action of PI3K, ERK and p38 MAPK signalling (Zhang et al., 
2010b). Recent evidence also demonstrates the involvement of Notch signalling in 
the regulation of TLR responses in macrophages including cytokine production, 
antigen presentation and cytotoxic activity (Monsalve et al., 2006, Hu et al., 2008, 
Palaga et al., 2008). It has also been implicated in TLR signalling in macrophages 
through modulation of the IFN# pathway (Hu et al., 2008). The involvement Notch 
in the TLR4/LPS recognition pathway will be further discussed in chapter 5.  
 
The use of zebrafish to study inflammation 
 
The zebrafish immune system 
 
 In the 1960s George Streisinger set out to find a model organism that was 
suitable for forward genetic manipulation and appropriate for modelling human 
diseases. His background as a fish enthusiast led him to choose a small tropical fish, 
the zebrafish (Grunwald and Eisen, 2002). After more than a decade of 
experimentation he successfully developed protocols that allowed the identification 
of germ-line mutations and eventually was able to produce homozygous diploid 
clones (Streisinger et al., 1981, Meeker and Trede, 2008). A description of zebrafish 
haematology first entered the literature in 1963 when it was demonstrated that blood 
cells formed early on in embryo development in the middle somatic region (Colle-
 
   42 
Vandevelde, 1963). Over the following decades zebrafish became a powerful tool in 
the study of developmental genetics, including the haematopoietic compartment. It is 
now clear that zebrafish can be used as a haematological model (Carradice and 
Lieschke, 2008). Zebrafish are genetically tractable and are ideal for large-scale 
mutagenesis screens. In the 1990s a large scale ENU mutagenesis screen produced 
over 4000 mutants that displayed defects in development which were used to identify 
genes involved in the development of the notochord, brain, spinal cord, somites, 
muscles, heart, circulation, blood, skin, fin, eye, otic vesicle, jaw and branchial 
arches, pigment pattern, pigment formation, gut, liver, motility and touch response 
(Haffter et al., 1996). Mutants in haematopoietic genes found by these screens have 
led to new models for disease and given insights in to developmental haematology 
(Brownlie et al., 1998). Zebrafish possess both an innate and adaptive immune 
system. The early immune system of the zebrafish is innate only, providing a tool for 
elucidating different roles for innate and adaptive immunity in response to 
inflammation and disease (Lam et al., 2002).  The genetic, morphological and 
functional similarities between the zebrafish and the human immune systems are 
many (Crowhurst et al., 2002, Lieschke et al., 2001). In fact, zebrafish possess most, 
if not all, of the cell types of the mammalian immune system (Berman et al., 2003, 
Traver, 2004). Zebrafish also possess many of the inflammatory mediators associated 
with the inflammatory response in mammals including orthologues of p38 MAPK, 
which will be discussed further in chapter four. The suitability of zebrafish as a 
model to study the mammalian immune system is outlined in Table 1 (taken from a 
review article by Meeker and Trede (2008)) comparing the zebrafish and mammalian 
immune system components.  
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Table 2. Overview of the zebrafish immune system and comparison to human. Taken 
from Meeker and Trede (2008). 
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 The zebrafish has several advantages over its mammalian counterparts as a 
model animal to study the immune system. Zebrafish is one of the smallest animals 
with a fully developed innate and adaptive immune system and therefore a large 
number of laboratory animals can be housed in a small space. These animals are also 
highly fecund with a single breeding pair able to produce in excess of 200 embryos 
per week. Additionally the embryos develop ex-utero and remain transparent for 
several days which both facilitate unrivalled visualisation of haematopoiesis and 
immune cell behaviour in a vertebrate model (Meeker and Trede, 2008). The 
zebrafish is a genetically tractable model organism. Now that the majority of the 
zebrafish genome has been fully sequenced, it is currently being assembled at the 
Sanger Institute, it has become clear that the zebrafish and mammalian genome maps 
have substantial conservation of syntenies (‘a pair of genes is syntenic if they are 
found on the same chromosome’) (Postlethwait et al., 1999). Zebrafish and other 
teleosts often have multiple copies of a single gene. This is caused by evolutionary 
genome duplication events (Postlethwait et al., 1998). This gene duplication can 
present an advantage over mammalian model organisms where knock out of a single 
gene of interest is embryo lethal. In zebrafish knock down of one copy of a duplicate 
gene can give insight into the function of that gene without producing an embryo 
lethal phenotype (Spitsbergen and Kent, 2003).The disadvantages of studying the 
zebrafish include the shortage of availability of monoclonal antibodies, that zebrafish 
cells respond poorly to cell culture and that currently there is no conventional gene 
knockout procedure (Meeker and Trede, 2008).  
 Zebrafish macrophages develop from the lateral mesoderm and are the first 
leukocytes to develop and emerge from the yolk sac (Herbomel et al., 1999).  By 48 
hours post fertilisation (hpf) macrophages and primitive neutrophils have developed 
and migrated away from the yolk sac (Herbomel et al., 2001, Le Guyader et al., 
2008). Once differentiated, some of these early migratory macrophages will move 
from the yolk sac to enter the circulation, whilst many migrate to the head of the 
embryo. These embryonic macrophages have several atypical characteristics. They 
seem to bypass the monocytic stage and retain proliferative capacity once 
differentiated (Herbomel et al., 1999). The zebrafish orthologue of the fms receptor 
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is known as csf1r and is expressed alongside the macrophage lineage marker pu.1 in 
macrophage progenitors (Parichy et al., 2000). A mutant in the csf1r gene, the 
panther mutant, was used to demonstrate that csf1r expression is required in the 
embryonic macrophage for successful emigration from the yolk sac and pericardial 
area. Mutations in this gene result in failure of the macrophages to colonise 
embryonic tissues (Herbomel et al., 2001). 
 Zebrafish have multi-lobular neutrophils, which highly express 
myeloperoxidase (MPO) (Bennett et al., 2001). Genes associated with the 
development of the adaptive immune system are expressed from 48 hpf, however 
mature lymphocytes do not develop until 3 weeks post fertilisation (Willett et al., 
2001). The period between fertilisation and the development of the adaptive immune 
system gives an opportunity to investigate the responses of the innate immune 
system to injury or disease in the absence of adaptive responses. Injury models in 
young embryos allow for screening of genes regulating, and compounds that 
modulate, leukocyte recruitment. Recently several studies have demonstrated that tail 
fin injuries such as tail transections (Lieschke et al., 2001, Renshaw et al., 2006, 
Niethammer et al., 2009) and medial fin incisions (Mathias et al., 2006, Brown et al., 
2007) can provide insights into the mechanisms of myeloid cell recruitment to a site 
of inflammation. Transgenic zebrafish lines exist in which green fluorescent protein 
(GFP) is expressed under immune cell lineage specific promoters and these will be 
further discussed in chapter three. The MPO::GFP zebrafish expresses GFP under the 
neutrophil specific MPO promoter (Renshaw et al., 2006, Mathias et al., 2006). 
Several studies have demonstrated that the neutrophil mediated inflammation might 
be resolved by retrograde migration from injured tissue back into the circulation 
(Mathias et al., 2006, Brown et al., 2007). Whilst the zebrafish embryo is a versatile 
tool for in vivo studies, adult fish can be used to extract blood cells for in vitro 
analysis. In 2003 Travers et al. demonstrated that the major blood lineages could be 
isolated by flow cytometry. The zebrafish blood cell types closely resemble their 
mammalian counterparts excepting the erythrocytes which are nucleated and the 
thrombocytes which perform the clotting functions that platelets perform in 
mammals (Jagadeeswaran et al., 1999).  
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Zebrafish models of bacterial infection 
 
 The similarities between the zebrafish and mammalian immune system have 
facilitated the emergence of zebrafish embryos and adult models of bacterial 
infection. Recent studies of Streptococcal infection in zebrafish have contributed to 
our understanding of bacterial virulence (Neely et al., 2002, Bates et al., 2005, Cho 
and Caparon, 2005, Miller and Neely, 2005, Montanez et al., 2005, Lowe et al., 
2007, Phelps and Neely, 2007, Kizy and Neely, 2009, Lin et al., 2009). Salmonella 
infection experiments in zebrafish have revealed conserved transcriptional responses 
in fish including TLR signalling, stress response factors and inflammatory mediators 
(van der Sar et al., 2006, Stockhammer et al., 2009). One of the most successful 
applications of bacterial infection in zebrafish has been their use in the study of 
mycobacterial infection. Embryonic infection with Mycobacterium marinum, a 
natural fish pathogen, has allowed the visualisation of infection in real time (Davis et 
al., 2002b), has shown that the mycobacteria replicate within macrophages and form 
granulomas as they do in mammalian infections (Clay et al., 2007, Clay et al., 2008), 
and has demonstrated macrophages in the granuloma undergo cell death and actively 
recruit macrophages from elsewhere in the embryo (Davis and Ramakrishnan, 2009). 
Adult zebrafish are also used to study the progression of mycobacterial infection. 
Adult infections can be chronic when low doses of mycobacteria are administered or 
acute with higher doses. Experiments using Rag1 fish that have no T-cells or B-cells 
demonstrated the requirement for adaptive immunity for the control of the infection 
(Swaim et al., 2006). Different strains of M. marinum cause either acute and lethal or 
chronic infections in adult zebrafish (van der Sar et al., 2004). Results of micro-array 
and RNA deep sequencing experiments have provided insights into mycobacterial 
response genes in the embryo and adult infections (Meijer et al., 2005, Hegedus et 
al., 2009, van der Sar et al., 2009).  
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• To reproduce, develop and extend the existing zebrafish systems in order to 
produce tractable models of inflammation in which immune responses can be 
analysed and modulated.  
• To use the zebrafish models developed to investigate the role of p38 MAPK 
in inflammation and the immune response. 
• To investigate the effects of mutations in genes within the Notch signalling 
pathway on inflammatory responses and development of the haematopoietic 




Zebrafish can be used as an informative model of mammalian inflammatory 
processes and reveal novel insights into the role of p38 MAPK and Notch signalling 
in the immune response.  
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CHAPTER 2. Materials and methods 
 
Zebrafish care and breeding 
 
Zebrafish Wild Type (WT) fish, transgenic fish were bred according to the 
Animals Scientific Procedures Act 1986. All fish were maintained according to 
standard practices (Nusslein-Volhard, 2002). Zebrafish abults were fed on a 
combination diet of Tetramin flake food and live brine shrimp (ZM Systems). 
MPO:GFP transgenic zebrafish were generated by Dr Stephen A Renshaw (Renshaw 
et al., 2006). zpu.1:EGFP zebrafish were generated by Professor Alistair C Ward  





obtained from Tübingen zebrafish stockcenter. 
 
Zebrafish models of inflammation 
 
In chapter three I have described the development and characterisation of 
different models of inflammation and their experimental results. There I give further 
details of experimental procedures used.  
 
Tail transection and tail nick injury, MPO staining of embryos and 
image acquisition 
 
 WT, mutant and transgenic embryos between 4 and 6-days-postfertilization 
(dpf) were anesthetized by immersion in system water with 4.2% tricaine (Sigma). 
Tail nick wound injury of the tail was performed by making a small wound using a 
19-gauge needle
 
to the ventral median fin posterior to the cloaca. Tail transection 
wound injury of the tail was performed using a sterile scalpel to transect and remove 
the distal tip of the tail. Embryos were untreated or exposed to LPS at a 
concentration of 1 or 10 µg/ml in system water using Escherichia coli LPS serotype 
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O55:B55 or Salmonella enterica LPS serotype typhimurium (Sigma). The inhibitor 
SB203580 (inhibitor of p38 MAPK), when used, was used at a concentration of 10 
µM (Sigma). The inhibitor DAPT (inhibitor of #-secretase), when used, was used at a 
concentration of 50 µM (Sigma). The concentrations of inhibitors used were based 
on previous experiments in the lab which determined effective inhibition versus 
toxicity.  
 Embryos for histological staining were incubated at 28.5°C in treatment media 
for the time indicated then killed with an overdose of tricaine. Embryos were fixed in 
4% paraformaldehyde in distilled water
 
for at least 1 h at room temperature before 
washing with 0.1%
 
Tween 20 in PBS and staining for MPO with 0.5 mg/mL 
diaminobenzidine,
 
0.03% hydrogen peroxide in PBS. Embryos were
 
imaged on a 
Zeiss Axiovert S100 for MPO-stained leukocytes and images captured using Open 
Lab v3.1 software (Improvision, Coventry, U.K.) and CoolSnap digital camera 
(Media Cybernetics, Silver Spring, MD).   
 MPO:GFP embryos used in in vivo time course experiments were wounded at 
time 0, placed in treatment media, then imaged at various time points and scored for 
GFP positive cells at the wound site.   
 zpu.1:EGFP  transgenic embryos used in time lapse imaging experiments were 
wounded at time 0, placed in treatment media for 2 hours then transferred to 0.8% 
low melt agarose (Flowgen, Lichfield,. UK) for imaging. Images captured using 
a Zeiss Axiovert 200 inverted microscope controlled by C-Imaging Simple-
PCI acquisition software. The time gap between two consecutive images was 15 
seconds. 
 
Mycobacterium marinum infection 
 
WT and DES embryos at 28 hpf were micro-injected in yolksac with dsRed 
transformed Mycobacterium marinum (strain M, ATCC BAA-535 (Ramakrishnan 
and Falkow, 1994)). Embryos were micro-injected into the yolksac using glass 
capillary micro-injection pipettes and forced air with a Narishige injection station 
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and micromanipulator with uniform volumes of M. marinum culture at an OD 
concentration of 0.5 and survival was monitored over time.  
 
Human neutrophil preparations 
 
Human neutrophils were prepared from the peripheral blood of healthy 
volunteers. Blood was separated using dextran sedimentation and a Percoll gradient 
yeilding highly pure human neutrophils (>95%). 
 
WKM (whole kidney marrow) extractions, coelomic cavity lavages and 
FACS sorting of immune cell populations.  
 
WKM and coelomic cavity cells were isolated from adult zebrafish.WKM 
and processed as previously described (Traver et al., 2003b, Moss et al., 2009). The 
cell isolates were washed, and resuspended in ice-cold Dulbecco's Modified Eagle 
Medium (DMEM) containing 10% fetal bovine serum (FBS), passed through a 
40µM sieve then analysed and sorted by flow cytometry using a FACSVantage with 
DiVa Option (Becton Dickinson) the myelomonocyte population has been previously 
described by Traver et al. (Traver et al., 2003b).  
 Extracted cells, when stimulated with LPS, were exposed to varying 
concentrations of E.coli LPS (serotype 055:B5 or 026:B6 as stated) or PMA (10 
ng/ml) and visualised/lysed for RNA at the times specified. The inhibitor SB203580, 
when used, was used at a concentration of 10 µM (Sigma).  
Stimulation with various concentrations of LPS (serotype 026:B6) or PMA 
(at 10 ng/ml) was performed on embryos at 5 days post fertilisation and WKM (cell 
suspensions prepared as described above) from adult fish and the tissues processed 
for cDNA.  
 For phagocytosis assays WKM cell suspensions were incubated at 28.5°C for 
two hours in IMDM media containing 10% FBS and 0.005 ng/ml 0.5 µM plain green 
fluorescent beads before collection of cell cultures, centrifugation and re-suspension, 
followed by cell sorting by flow cytometry.  
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Development of in vivo computational automated cell tracking model; 
Image processing and data transformation: 
 
The images analysed contained fluorescent PU.1 positive cells. All images 
were processed in R using the package EBImage. Cells were detected with an edge 
detection method using a threshold for the light intensity. Each detected cell was 
described as an object with the coordinates of its geometrical centre describing the 
cell location and the occurrence time (Fig. 3a). The cells were tracked over time 
using a surface-tracking algorithm that is not based on any prior knowledge about the 
dynamical behaviour. Because the time-lapse microscopy data are optimized in the 
experimental setup, e.g. 15 sec time gap between two consecutive images, double 
tracking error was avoided (Beltman et al., 2009). All cell trajectories that included 
time points in which the cell was located at the edge of the image were excluded. 
The images contain the zebrafish tail with the whole transection wound and only 
those trajectories with a distance to the injury of less than 800 µm were included. 
Only trajectories that contain more than 50 time steps were used for the analysis in 
order to improve the reliability of the results. Bright field and fluorescent images 
were produced at each time point to correct for small movements of the zebrafish.  
 
To analyse the extracted image data more efficiently and to combine or 
compare data from several movies it was necessary to normalize them, e.g. the 
reorientation of the object positions in respect to the blood vessel of the fish. This 
was achieved by using linear transformation. The transformation describes the 
rotation and shifting of the new coordinate bases in the way that the blood flow 
describes the y-axis and orthogonal to it the x-axis, which is located approximately 
parallel to the wound (Fig. 3b). The orientation is based on the bright field images. 
 
Dynamical models 
The trajectories obtained were tested for a random walk. The random walk 
(Hannigan et al., 2001) is described as: 
 








with the vector A of the diffusion coefficients, and the probability density function 
P(x,y,t) of the object location at time t. The null hypothesis H0 states that the tested 
trajectory shows a random walk. Two aspects of a random walk were analysed. As a 
first criterion the distribution of the angles between two vectors of the trajectory was 
tested for uniformity, i.e. whether the motion vectors are isotropic (see Figure 14 in 
chapter 4), using the Kolmogorov-Smirnov test. Additionally the distribution of the 
length of the vectors was investigated. This was done for the entire vector and its 
projections onto X and Y direction, respectively. These distributions were tested for 
normality with a Kolmogorov-Smirnov test for normal distributions. The 
directionality coefficient D was calculated as the coefficient of the shortest distance 
between the start and end point of a trajectory and the actual length of the trajectory. 
A D-value close to one indicates highly directed movement and a D-value close to 
zero indicates that the movement is not directed. Note D-value close to zero does not 
necessarily imply that the cell performs a random walk as described in equation 1. A 
permutation test was used for all significance analyses. Juliane Liepe developed this 
computational automated cell tracking system.  
 
Preparation of RNA and cDNA from Embryos and Adult tissue 
 
 Zebrafish embryos were administered a lethal dose of MS-222 (Sigma, see 
appendix I). MS-222 was removed and embryos were homogenised using a sterile 
pestle in lysis buffer. Cells were lysed directly in lysis buffer. RNA was isolated 
from embryos and cells using MagmaxTM-96 total RNA isolation kit (Ambion Inc) 
following the manufacturers protocol. The quality and quantity of RNA was assessed 
spectrophotometrically using a Thermo Scientific NanodropTM 1000. For cDNA 
synthesis, 85 ng of mRNA was reverse transcribed using a high capacity cDNA 
reverse transcription kit (Applied Biosystems) following the manufacturers protocol. 
Quantitative RT-PCR was performed with Taqman Fast Universal assays (Applied 
Biosystems) using a 7500 Fast instrument. The quantitative PCR amplification 
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program used was as follows, 95°C for 20 s (1 cycle), 95°C for 3 s then 60°C for 30 s 
(40 cycles). Results were normalized to 18S and calibrated to untreated samples 
unless otherwise stated. The Taqman gene expression assay IDs for assays used are 
shown below. 
 









hes1 Custom design 
 
Expression of genes for which Taqman assays were unavailable was determined by 
SYBR green qPCR analysis and the sequences designed against these transcripts are 
given below.  
 
Gene Forward Primer sequence 5’-3’ Reverse Primer sequence 5’-3’ 
tnfa CCATTTAACAGGTGGATACAAC CCATCATCGGGAATGATAATCTCC 
il-8 TGTGTTATTGTTTTCCTGGCATTTC CTGTAGATCCACGCTGTCGC 
ef1!  GGAAGCCGCTGAGATGGCAAGG GGTACTTCTCAGGCTGACTGTGC 
 
 
All primers were checked for hairpins, palindromic sequences and dimers 
using Net Primer and were used at 0.5µM final concentration in PCR reactions. 
Single product amplification was confirmed by carrying out dissociation (melting) 
curve analysis post-amplification. Relative gene expression levels are normalised 
against the housekeeping gene elongation factor 1 alpha (ef1-!).  
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Western blot analysis 
  
 Embryos at 4dpf were treated with appropriate media and incubated for one 
hour at 28.5°C before overdosing with tricaine. Zebrafish tissue samples were 
harvested from whole embryo tissue using a sterile pestle with detergent free lysis 
buffer. The lysates were cleared by centrifugation then re-suspended in laemmli 
buffer containing 5% b-mercaptoethanol and boiled at 100°C for 5 min. Samples 
were analysed by SDS-polyacrylamide electrophoresis (12%). Samples analysed by 
SDS-polyacrylamide gels were electroblotted onto nitrocellulose membranes 
(HybondTM-ECLTM) (Amersham Biosciences). Membranes were stained with 
ponceau red followed by two brief (5 min) washes with 0.05% Tween-20 in PBS 
(PBS-T). Non-specific binding was blocked with 5% dried milk (marvel) prepared in 
0.05% Tween-20/PBS for one hour at room temperature. The primary antibody used, 
Anti-ACTIVE® p38 pAb (Promega), was prepared in 5% marvel/PBS-T (1:1000) 
and incubated with membranes overnight at 4°C. Membranes were washed three 
times (5 min per wash) with 0.05% Tween-20/PBS (PBS-T). An Anti-rabbit HRP 
conjugated sencondary antibody was prepared in 5% marvel/PBS-T (1:2500) and 
incubated with membranes for 2 hours at room temperature. Membranes were 
washed three times then treated with SuperSignalR West Pico chemiluminescent 
substrate for detection of HRP (Thermoscientific) (prepared following the 
manufacturers protocol) for 5 min in the dark. All blots were visualised using an 
ECL detection system (BIO- RAD). 
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Chapter 3. Characterisation of experimental models of 
inflammation in zebrafish 
 
Aims and Introduction: 
 
Aims: 
• To reproduce and develop the existing zebrafish systems in order to produce 
tractable models of inflammation in which immune responses can be 




The p38 MAPKs are a family of stress-activated proteins central to cellular 
responses activated by external stimuli. They are candidate drug targets for treatment 
of a broad range of inflammatory diseases including asthma (Adcock et al., 2008), 
rheumatoid arthritis (Thalhamer et al., 2008) and atherosclerosis (Osman et al., 
2008). LPS is a potent activator of p38 MAPK (Sweet and Hume, 1996) that 
regulates the translation and transcription of the inflammatory cytokines IL-1 and 
TNF (Adams et al., 2001). Inhibitors of p38 MAPK prevent the translation and 
transcription of IL-1 and TNF either directly or indirectly via the action of 
downstream protein MAPKAP K2 (Kumar et al., 2003). The MAP kinases are 
highly conserved across species and zebrafish possess 2 isoforms of the mammalian 
p38! gene. The aim in this chapter is to establish models of acute inducible 
inflammation in zebrafish to use in later chapters to test the role of p38 MAPK using 
pharmacological inhibitors. 
Several studies have demonstrated that tail fin wounding in zebrafish 
embryos, including tail transections, medial fin incisions and laser-inflicted wounds 
induce the migration of leukocytes to the site of tissue damage (Lieschke et al., 2001, 
Renshaw et al., 2006, Mathias et al., 2006, Brown et al., 2007, Redd et al., 2006). In 
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particular neutrophil mediated responses to acute wounding have been demonstrated 
using a combination of histochemical staining of fixed embryo tissue for the 
neutrophil specific marker MPO and transgenic zebrafish lines expressing 
fluorescent proteins under the MPO promoter (Renshaw et al., 2006, Mathias et al., 
2006, Loynes et al., 2009). Here the aim was to add to the complexity of these 
models of injury induced acute inflammation by introducing other inflammatory 
signals, such as exposure to LPS, and determine their effect on the resulting 
leukocyte recruitment. The acute wound injury models developed in this chapter will 
be used in chapter four to investigate the differential effects of inhibiting p38 MAPK.  
The search for lineage specific markers in the innate immune system in 
zebrafish embryos has been a goal of many research groups in recent years. The 
complex overlap in expression of various candidate markers has led to controversy 
over the definition of macrophage and neutrophil cell types specifically. The lack of 
tools, e.g. monoclonal antibodies, for identifying leukocytes in zebrafish has 
compounded this problem. However the use of histochemical staining and the 
production of several transgenic lines of fish expressing fluorescent proteins under 
the control of potential lineage specific markers has allowed distinctions between 
innate immune cells to be made. Transgenic lines with promoter driven fluorescent 
cell types include the pu.1, MPO, lyzC, and Fli1 (Ward et al., 2003, Mathias et al., 
2006, Renshaw et al., 2006, Hall et al., 2007, Lawson and Weinstein, 2002) and here 
I describe the studies that have revealed how expression of these and other cell 
markers define specific leukocyte cell types in zebrafish. Herbomel et al. first 
described l-plastin as a haematopoietic marker gene for macrophages (Herbomel et 
al., 1999). Bennett et al. used in situ hybridisation techniques to determine the 
expression and co expression of the haematopeitic markers marker mpo, l-plastin and 
pu.1 (Bennett et al., 2001). l-plastin expression was localised to anterior yolk region 
of early embryos which was consistent with the findings of Herbomel et al. 
(Herbomel et al., 1999, Bennett et al., 2001). Double in situ hybridisation determined 
the presence of cells that coexpressed mpo and pu.1 but no cells that coexpressed 
mpo and l-plastin. This distinct expression of mpo and l-plastin indicated mpo 
expression was specific to granulocytes and that l-plastin expression was specific to 
macrophages (Bennett et al., 2001). Coexpression of mpo and pu.1 was transient 
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indicating a role for pu.1 expression in regulation of the development of myeloid 
progenitors into mature neutrophils (Bennett et al., 2001). Lieschke et al. used MPO 
histochemical staining to stain granulocytes in zebrafish embryos, which they termed 
heterophils, and which were functionally similar to mammalian neutrophils 
(Lieschke et al., 2001). mpo expression and morphological characteristics in cells of 
the zebrafish adult kidney and embryonic myelopoeitic regions confirmed in 
zebrafish mpo expression is restricted to cells of the granulocyte lineage as it is in 
humans (Bennett et al., 2001). The MPO:GFP transgenic zebrafish line was 
produced and described by two groups independently in 2006 (Mathias et al., 2006, 
Renshaw et al., 2006). Both groups produced fish expressing GFP under the control 
of the MPO promoter and based on previous descriptions of MPO as a neutrophil-
restricted granule protein they both defined these MPO expressing cells as 
neutrophils.   
Lui et al. discovered the lysozyme C gene (lyzC) another marker for the 
myeloid lineage cell types in the embryo (Liu and Wen, 2002). They defined this 
lyzC gene as a macrophage specific marker on the strength of it being co-expressed 
with pu.1 and l-plastin genes. However as both of these genes are broad myeloid 
lineage markers this is now considered an over interpretation of the results and a 
macrophage specific marker remained to be found. lysozyme C as a candidate 
macrophage lineage marker was further investigated in 2007 when Hall et al. 
produced a transgenic zebrafish line expressing EGFP and DsRED2 under the 
lysozyme C  promoter (Hall et al., 2007). Hall et al. scrutinised the expression 
profiles of the fluorescent lysozyme C expressing cells in these transgenic fish and 
found labelled cells expressed markers of the macrophage lineage including l-plastin. 
However they also detected mpo transcripts within some of these cells and so 
concluded the lysC::EGFP and lysC::DsRED2 reporter lines as having marked 
myelomonocytic compartments (Hall et al., 2007). Meijer et al. used a transgenic 
zebrafish line showing leukocyte specific YFP expression, generated from a large-
scale enhancer detection screen in the zebrafish genome (Ellingsen et al., 2005), to 
re-examine the specificity of described myeloid markers. This myc/YFP-expressing 
cell type in the zebrafish embryo was determined to mark a subset of granulocytes 
and by carrying out co-localization analysis they reexamined existing markers and 
 
   58 
that showed l-plastin can be considered a general leukocyte marker, csf1r can be 
considered a macrophage specific marker, and mpx and lysozyme C can be 
considered neutrophil specific markers (Meijer et al., 2008). Meijer et al. point out 
that caution should be employed when using the described myeloid marker genes in 
zebrafish. Temporal considerations must be made as co localization of different cell 
markers can change over time, for example cellular co-localization of l-plastin and 
mpx was found to reduce over time which could explain why other groups did not 
observe overlap in expression of these genes (Meijer et al., 2008). Currently whilst 
mpx can be described as neutrophil specific and csf1r can be described as 
macrophage specific all other markers share some form overlap with these markers 
and so are less specific markers of the myeloid compartment and must be used in 
combination with other markers when describing cell type. Here I report cell 
recruitment to the acute injury models in zebrafish embryos using a combination of 
histochemical staining and transgenic fish expressing fluorescent proteins under 
lineage defining promoters.  
  The unique combination of optical translucency, which allows in vivo imaging 
of host responses in real-time, and genetic tractability, allowing the production of 
transgenic fish expressing fluorescent proteins under lineage specific promoters, 
have made zebrafish invaluable in the study of host/pathogen interactions to a variety 
of infectious organisms including mycobacteria (Davis et al., 2002a, Prouty et al., 
2003, Clay et al., 2007, van der Sar et al., 2006, Stockhammer et al., 2009). M. 
marinum is a strain of mycobacterium closely related to Mycobacterium tuberculosis 
and causes tuberculosis in ectotherms using similar pathogenic mechanisms (Clark 
and Shepard, 1963, Clay et al., 2007). Here I report a mycobacterial infection model 
in zebrafish embryos that is comparable to those reported by others (Davis et al., 
2002a, Clay et al., 2007). I have used this infection model to study the role p38 
MAPK and defects in members of the Notch signalling pathway on survival and 
present the results of these experiments in subsequent chapters.  
The immune system of adult zebrafish has been characterised in several 
studies. The WKM is the haematopoietic organ in all adult teleosts including 
zebrafish (Zapata, 1979) and was characterised in zebrafish by Traver et al. who 
isolated each of the major blood lineages by flow cytometry (Traver et al., 2003b).  
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Adult immune cells including granulocytes, lymphocytes and non-specific cytotoxic 
cells (NCCs), can also be isolated from adult zebrafish by lavaging the coelomic 
cavity (Moss et al., 2009). In this chapter I describe the isolation and characterisation 
of cell populations from the WKM and coelomic cavity of adult fish, which I have 
used in subsequent chapters to analyse zebrafish immune cell responses to 
inflammatory stimuli and pharmacological inhibitors.   
Here I will introduce and characterise the various models that will be used 
throughout this thesis to examine the role of p38 MAPK and Notch signalling in the 
zebrafish immune response.  
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Results 
 
Acute wound injury models: tail nick and tail transection 
 
Kinetics and quantitative analysis of leukocyte recruitment/retention 
 
Using fixed and MPO stained (neutrophil selective marker) WT embryos at 5 
dpf I demonstrate that a tail nick injury in the ventral fin or tail transection injury of 
the distal tip of the tail induced neutrophil recruitment to the site of the wound injury 
(Figure 1 A & B respectively). Neutrophil recruitment to a tail nick wound injury is 
highest (5 cells) at 2 hours post injury (hpi) and resolution of neutrophillic 
inflammation is largely complete (0 cells) by 6 hpi (Figure 3 A).  Recruitment to a 
tail transection injury is highest (6 cells) at 4 hpi and by 8 hpi the number of MPO 
positive cells at the site of injury is reduced (3.5 cells) (Figure 3 B).   
 
Effects of wound size/depth and LPS on leukocyte migration 
 
Both the size and depth of tail nick wound injuries influence cell migration 
and/or retention. Embryos were nicked midway along the ventral median fin and the 
wounds were scored small, medium and large according to the depth of the cut. 
Small wounds (Figure 2 A) are defined as incisions that go to a depth no greater than 
25% the distance between the outside edge of the fin and the vasculature. Medium 
wounds (Figure 2 B) are defined as incisions that go to a depth of greater than 25% 
and no greater than 75% the distance between the outside edge of the fin and the 
vasculature. Large wounds (Figure 2 C) are defined as incisions that go to a depth 
greater than 75% the distance between the outside edge of the fin and the 
vasculature. The level of neutrophil recruitment is associated with the size of the tail 
nick wound inflicted. There is a hierarchical neutrophil recruitment with large 
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wounds > medium wounds (P<0.01) > small wounds (Figure 2 D). For this reason 
only wounds classed as medium sized were included in any data analysis to avoid 
any bias caused by variations in wound size.  
Having determined the peak time for neutrophil recruitment, in unstimulated 
fish with wound injury I investigated the effect of the bacterial derived cell wall 
component LPS. In both models of injury, tail nick and transection, stimulation with 
LPS resulted in an increase in cell recruitment at the peak time points 2 and 4 hpi 
respectively (Figure 4 & Figure 5). I demonstrate that in the presence of LPS there is 
an increase in the number of neutrophils migrating to an acute tail nick (Figure 4 A 
& B). Immersion of embryos wounded by tail nick injury in E.coli LPS significantly 
(P<0.001) enhanced neutrophil 2 fold (Figure 4 A & B). Similarly the immersion of 
embryos wounded by tail transection in E.coli LPS significantly (P<0.001) enhanced 
neutrophil recruitment/retention (Figure 5 A & B).  
 
Injury in transgenic embryos allows monitoring of leukocyte recruitment in 
individual live embryos over time.  
 
 Using transgenic zebrafish expressing GFP under the neutrophil specific 
MPO promoter (Renshaw et al., 2006) I demonstrate that LPS at 1 µg/ml 
significantly enhanced recruitment of neutrophils post injury in live embryos (4 & 5 
dpf) at 4, 5 and 6 hrs (P<0.05) when compared to cell migration in response to 
wounding alone. By 24 hrs the number of neutrophils at the site of injury is reduced 
(Figure 6 A).  During the first 4 hrs of injury the recruitment/retention of cells was 
significantly greater in the fish exposed to LPS (the slopes of the linear regression 
lines were significantly different, p<0.02; (Figure 6 B). In the presence of LPS I 
noted that there was an increase in the number of neutrophils recruited to and/or 
retained at the site of injury but that the kinetics of the migration remained the same 
as that observed in wounding alone, i.e. there was no change in the peak time point at 
which maximal recruitment was observed (Figure 6 A).  
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 I confirmed that it was also possible to follow recruitment of leukocytes to a 
tail transection injury in the myeloid lineage specific zpu.1:EGFP transgenic 
embryos, as was possible with the MPO:GFP fish. Time lapse microscopy images of 
recruitment to a tail transection wound demonstrates fluorescent immune cells are 
visible and can be seen migrating in the injured tail (Figure 7). The model of cell 
recruitment and tracking of cells in zpu.1:EGFP transgenic embryos is further 
developed in chapter four of this thesis where the effect of LPS exposure is 
comprehensively investigated.  
 
Embryo infection models 
 
Development of M. marinum infection model in zebrafish embryos 
 
 In order to develop and characterise a model of embryonic bacterial infection 
in zebrafish dsRED M. marinum was micro-injected into the yolk sac of embryos at 
24 hpf (Figure 8 A). The spread of the bacterial infection throughout the embryo was 
visualised (Figure 8 B, D & C) and survival time monitored (Figure 8 E). At 24 hpi 
dsRED M. marinum was visible within the yolk sac and by 72 hpi was disseminated 
throughout the embryo and present in the tissues. By 72 hours bacteria are 
concentrated in aggregates within the vascular bed of the tissue of the tail posterior to 
the yolk sac (Figure 8 D). Embryos injected with M. marinum survive until 4 dpi 
when they begin to die and by 6 dpi there are none surviving. In contrast, the survival 
rate of control embryos injected with PBS is higher with 75% of injected fish alive at 
6 dpi (Figure 8 E). As a result of trauma caused by micro-injection ~20% of PBS 
injected embryos die within the first 2 dpi (Figure 8 E).  
 M. marinum is disseminated throughout zebrafish embryos by migrating 
macrophages when injected via the caudal vein (Clay et al., 2007). Transgenic 
zebrafish expressing eGFP under the myeloid lineage specific Pu.1 promoter were 
injected in the yolk sac with dsRED M. marinum. At 24 hpi several dual positive 
(Pu.1
+
 and dsRED M. marinum positive) were visible outside but close to the yolk 
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sac (Figure 9 A). However, by 48 hpi many dsRED positive cells were visible 
throughout the tail and of these a number were also positive for GFP indicating they 
had been engulfed by Pu.1 positive leukocytes (Figure 9 B). dsRED positive cells 
were also disseminated throughout the head at 48 hpi but due to the high GFP 
expression in the yolk sac and the greater depth of the tissue it is difficult to 
determine the dual positive cells in this region of the embryo (Figure 9 C). At 6 dpf 
95% of zPu.1:eGFP transgenic embryos injected with M. marinum are dead 
compared with 15% of control embryos injected with PBS only (Figure 9 D) which 
is consistent with the rate of survival in the WT fish.  
 
Isolation and characterisation of immune cell populations from adult 
zebrafish 
 
Isolation and characterisation of cells from adult WKM 
 
 The haematopoietic organ in the adult zebrafish is the WKM. This organ can 
be dissected from adult zebrafish and processed to produce cell suspensions (Traver 
et al., 2003b). Here cell suspensions were produced from WT adult zebrafish, 
analysed by flow cytometry, and sorted according to forward and side scatter with 
the aim of isolating a monocyte/macrophage population. Five populations were 
sorted (Figure 10 A) and cytospins performed in order to characterise the 
morphology of the cells in each population. Two large populations within the red 
gate contain mature erythrocytes. Cells within the green gate displayed 
granulocyte/monocyte characteristics. The blue gate contains only lymphocytes and 
the purple gate contains mainly precursor cell types and with some lymphocyte and 
granulocyte/monocyte cell types (Figure 10 A). The populations identified and 
characterised in this study correspond with the findings of Traver et al. who 
established that there are two populations of cells of low forward scatter identified as 
erythrocytes, a population of intermediate forward scatter (FSC) and low side scatter 
(SSC) identified as lymphocytes, a population with intermediate FSC and 
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intermediate SSC identified as precursors and finally a population of high FSC and 
high SSC identified as myelomonocytes (Traver et al., 2003b).  
 It is possible to sort a mixed population of myeloid cells from zebrafish 
whole kidney using forward and side scatter. In order to isolate a purer population of 
macrophage-like cells, with a view to carrying out in vitro M. marinum phagocytosis 
and expression assays, the WKM cell suspensions were sorted based on their ability 
to phagocytose fluorescent beads. WKM cells were isolated and the cell suspensions 
were cultured with 500 nM fluorescent Latex beads at 28.5°C for 2 hours before 
sorting for fluorescent positive cells. The fluorescent positive cell population was 
analysed microscopically and whilst a significant population of the sorted cells had 
taken up beads by phagocytosis, largely mononuclear phagocytes (Figure 11 A), 
there was a contamination from other cell types negative for fluorescent beads. In 
order to optimise the enrichment for phagocytic cells those cells that exhibited high 
fluorescence, containing two or more beads, were gated and sorted. Those cells that 
had low fluorescence or were negative for fluorescence were also sorted and the 
three populations were then analysed by flow cytometry a second time to determine 
the purity of these cell populations. This analysis revealed that the population 
originally sorted as negative for fluorescence remained 99.9% negative. The 
population sorted for low fluorescence had lost much of the positive fluorescence; 
only 6% of the cells had retained positive fluorescence. Of the highly positive 
population 25% of the cells sorted as positive retained their fluorescence in the test 
sort (Figure 11 B). Microscopic examination confirmed that 25% of the cells sorted 
as highly positive had engulfed the beads. Total sorted cell number in this GFP high 
population was low (< 200 000) and whilst there were enough cells to perform 
cytospin analysis the yield for total RNA isolated was very poor (< 0.1 µg) (Figure 
11 C). Total sorted cell number in populations that were sorted on forward and side 
scatter alone, myelomonocytes, lymphocytes, precursors and erythrocytes, were 
higher (>600 000, >1500 000, >900 000 & >500 000 respectively (Figure 11 C). The 
myelomonocytic population of interest produced a higher, but still low, amount of 
total RNA (< 1.0 µg) (Figure 11 C). 
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Phenotypic characterisation of cells isolated from coelomic lavage of adult 
zebrafish 
 
 Leukocytes are present in the coelomic cavity of adult zebrafish (Moss et al., 
2009). The coelomic cavities of adult WT fish were flushed to produce cell 
suspensions that were subsequently analysed by flow cytometry. The forward and 
side scatter profiles produced were similar to those described by Moss et al. (2009).  
A population of cells with FSC
high
 and SSC 
high
 (Figure 12 A red gate) was identified 
which, when stained with Wright Geimsa stain, was enriched for myelomonocytes 
and macrophage-like cells. Two populations of SSC
low 
cells were found and these 
were composed of small cells with high nuclear:cytoplasm ratios. The positions of 




 subset is the 




phenotype are the lymphocyte containing population when classified according to the 
findings of Moss et al. (2009) (Figure 12 A blue and green gates).  However, in 
contrast to the results of Moss et al. (2009) I did not identify an erythrocyte 






Relative expression of lineage markers in sorted WKM and coelomic cavity 
cells  
 
 In order to further characterise the cell types sorted from adult WKM and 
coelomic cavity, expression of lineage specific markers was carried out. Relative 
expression of macrophage specific cell marker csf1r was assessed in WKM sorted 
cell types and found to be most highly expressed in the precursor group with >25 
fold increase in expression than both the myelomonocyte and lymphocytes 
populations (Figure 13). Relative expression of neutrophil specific cell marker mpo 
was found to be most highly expressed in the WKM derived myelomonocyte cell 
type with >450 fold increase in expression relative to the lymphocyte with 
expression in the precursor population 35 fold higher than the lymphocyte population 
(Figure 13). Expression of pan myeloid marker pu.1 was found to be most highly 
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expressed in the WKM derived myelomonocytic population, >6 fold above the level 
of expression in the lymphocyte cell type, and expression in the precursor cell type 
was 2 fold above that of the lymphocyte cell type (Figure 13). Relative expression of 
macrophage specific cell marker csf1r was assessed in coelomic cavity sorted cell 
types and found to be equally highly expressed in the macrophage/granulocyte and 
the NCC cell types with >6 fold increase in expression above the lymphocyte 
population (Figure 13). Relative expression of neutrophil specific cell marker mpo 
was found to be most highly expressed in the coelomic cavity derived NCC cell type 
with >200 fold higher expression relative to the macrophage/granulocyte and 
lymphocyte cell types (Figure 13). Expression of pan myeloid marker pu.1 in the 
coelomic cavity derived cell types was found to be equally highly expressed in the 
macrophage/granulocyte and the NCC cell types with >6 fold increase in expression 
above the lymphocyte population expression in the precursor cell type was 2 fold 
above that of the lymphocyte cell type (Figure 13). 
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Figures 
 
Figure 1. Diagram and image of MPO stained tail nick (A) and tail transection 
wound (B). Embryos wounded at 5 days post fertilisation (dpf) and incubated for 2 
(A) and 4 (B) hpw before fixing in 4% paraformaldehyde and staining for MPO.  
 




Figure 2. Examples of representative tail nick wound sizes in embryos (2 hpi) fixed 
and stained for MPO activity, small (A), medium (B) and large (C) and graph 
showing median number of MPO stained cells recruited against wound size in the 
presence of 1µg/ml LPS (D) (n = >90 embryos per bar, error bars are 95% CIs). 
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Figure 3. Time course showing recruitment of MPO stained cells to tail nick (A) and 
tail transection injury (B). Embryos at 5dpf were wounded, incubated in system 
water then killed and fixed at various time points post wounding and histochemically 
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Figure 4. LPS treatment enhances recruitment of MPO stained cells to a tail nick 
wound injury. Embryos at 5 dpf were wounded and immersed in system water alone 
or system water containing E.coli LPS (serotype 055:B5) at 1 µg/ml. Graphs 
represent one data set presented as a bar chart (A) and a dot plot (B) (n = >40 
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Figure 5. LPS treatment enhances recruitment of MPO stained cells to a tail 
transection wound. Embryos at 5 dpf were wounded and immersed in system water 
alone or system water containing E.coli LPS (serotype 055:B5) at 1 µg/ml. Graphs 
represent one data set presented as a bar chart (A) and a dot plot (B) (n = >30 
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Figure 6. LPS treatment enhances recruitment of neutrophils to a tail wound in 
MPO:GFP zebrafish embryos (3 & 4 dpf). Embryos were wounded then immersed 
in system water (!) or E.coli (eLPS, 055:B5) (!) at 1 µg/ml and MPO:GFP positive 
cells recruited to the wound were recorded over time. Time course over 24 hours 
showing recruitment of fluorescent cells is recorded over time and analysed using 
Mann Whitney test (A). The same time course data up to 4 hours presented with 
linear regression lines. The slopes of the linear regression lines were significantly 
different, p<0.02 (B). (n = >20 embryos per data point, error bars are 95% CIs). 
Bright field and GFP time-lapse image montage of a tail transection injury in 
transgenic MPO:GFP embryo starting at 1 hpw with 120 sec gaps between images 
(C).
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Figure 7.  Bright field and GFP time-lapse image montage of a tail transection injury 
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Figure 8. WT Embryos infected with dsRED M. marinum. Schematic illustrating 
location of injection of M. mariunum in yolk sac at 24 hpf (A). Image of embryo 
infected with dsRED M. marinum localised to yolk sac at 24 hpi (B). Image of 
embryo infected with dsRED M. marinum localised to yolk sac at 48 hpi (C). Image 
of embryo infected with dsRED M. marinum localised in aggregates within the 
vascular bed of the tissue of the tail posterior to the yolk sac at 72 hpi (D). Percent 
survival of WT embryos micro-injected with either PBS of dsRED M. marinum at 24 
hpf with >35 embryos per condition (E). 
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Figure 9. Infection of zpu.1:EGFP  transgenic embryos with dsRED Mycobacterium 
marinum. Image of cloaca region of the tail of an infected zpu.1:EGFP embryo at 24 
hpi showing GFP Pu.1 positive cells and two dual positive (eGFP and deRED) cells 
(A). Image of the tail of an infected zpu.1:EGFP embryo at 4 hpi showing eGFP Pu.1 
positive cells, dsRED positive cells and dual positive cells (B). Image of head of an 
infected zpu.1:EGFP embryo at 48 hpi showing disseminated dsRED positive cells 
(C). Images chosen are representative of embryos at each stage of infection. Percent 
survival of zpu.1:EGFP embryos micro-injected with either PBS of dsRED M. 
marinum at 24 hpf with >12 embryos per condition (D). 
 
 




Figure 10. FACS profile of WKM cell suspensions and cytospins showing sorted 
cell population morphology. Cell types sorted are erythrocytes (red gate) 
lymphocytes (blue gate) precursor cell types (purple gate) and myelomonocytic cells 
(green gate) (A). FACS profile of WKM cell suspensions and cytospins showing 
sorted cell population morphology taken from Traver et al. [2003b] (B). 
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Figure 11. Enriched populations of mononuclear phagocytes can be isolated by flow 
cytometry. WKM cell suspensions were incubated with 0.5 micro fluorescent beads 
for 2 hours and then sorted by flow cytometry into 3 populations (negative, low and 
high) according to their fluorescence. The sorted populations were then passed 
through the flow cytometer again to determine the level of fluorescence retained by 
the cells post sorting. FACS plots indicating the proportion of cells that retained their 
fluorescence post sorting in the negative, low and high sorted populations (A). 
Cytospins of sorted WKM cells that have phagocytosed the fluorescent beads (B). 
Table indicating total cell counts and amounts of RNA purified from populations 
sorted by flow cytometry (C).  
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Figure 12. Flow cytometry plot showing populations of cells isolated from the 
coelomic cavity of adult zebrafish. Cell types sorted are myelomonocyte/granulocyte 
containing gate (red) nonspecific cytotoxic cell (NCC) containing gate (blue) 
lymphocyte containing gate (green). Flow cytometry profile of coelomic cavity cell 










) is described as the erythrocyte containing 




) is described as the lymphocyte 




) is described as the NCC 
containing population. Adapted from Moss et al. (Moss et al., 2009) (B).  
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Figure 13. Quantitative PCR analysis of expression of the zebrafish lineage specific 
cell markers csf1r, mpo and pu.1 expression in sorted cell populations from adult 
WKM tissue and coelomic cavity cells. WKM and coelomic cavity cells extracted 
from adult fish were sorted as described and cells lysed and processed for cDNA. 
Gene expression is normalised to 18S and is presented as relative to the population 
expressing lowest levels of transcript.  
 




 In this chapter I have established and characterised the various models of 
inflammation that will be used throughout this thesis to examine the role of p38 
MAPK and Notch signalling in the zebrafish immune response.  
 
Acute wound injury models: tail nick and tail transection 
 
I have investigated the neutrophil recruitment response in two previously 
described types of zebrafish embryonic tail fin injury, the tail nick injury (Mathias et 
al., 2006, Brown et al., 2007, Cvejic et al., 2008) and the tail transection injury 
(Renshaw et al., 2006) with the aim of extending these models to include additional 
inflammatory stimuli, and then to apply these models to study the dynamics of 
leukocyte recruitment and its dependency on p38 MAPK. The number of neutrophils 
recruited to the injuries was comparable to that of work published by previous 
groups. The peak of neutrophil recruitment in the tail nick model was 2 hpw with a 
mean total of 5 cells which is comparable to results presented by Cvejic et al. who 
recorded an average of 7 neutrophils at the wound site at 1.5 hpw (Cvejic et al., 
2008). The peak time of neutrophils migration in tail transection wounds was 4 hpw 
and confirms the findings of Renshaw and colleagues. However the magnitude of the 
response they observed was greater, ie. a mean cell number of 10 cells at 4 hpw 
(Renshaw et al., 2006). It is possible that this difference reflected variation in 
severity of wounding. Renshaw et al. performed a complete transection of the tail 
severing the blood vessels in the vascular tissue at the distal tip of the tail. Here I 
transect only the distal tip of the fin avoiding damage to the vasculature. This less 
severe injury results in recruitment of fewer neutrophils but allows greater accuracy 
in the counting of the recruited neutrophils, which can are difficult to count 
individually when very high numbers are observed. When higher numbers of cells 
are recruited in more severe injury (Renshaw et al., 2006) the cells overlap and it is 
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necessary to approximate cell number by quantifying the overall size of the 
fluorescent area.  
I demonstrate in vivo that LPS enhances the number of recruited neutrophils 
to a site of injury. LPS induced elevated numbers of MPO cell counts in tail nick and 
transection injuries as measured by staining of fixed embryos and imaging of injuries 
in live transgenic MPO:GFP embryos over time. The presence of bacteria in the 
water of wounded embryos has been shown to enhance leukocyte recruitment to 
wound injury in zebrafish embryos (Brown et al., 2007). Here I show that the 
bacterial component LPS alone is sufficient to induce a significant enhancement in 
neutrophil recruitment to wound injury. Neutrophil recruitment has been investigated 
in other models of LPS mediated inflammation such as LPS induced lung injury 
(Chignard and Balloy, 2000). However in this in vivo study I report that LPS can 
induce an increase in neutrophillic inflammation at sites of surgical wound injuries. 
It is likely that this LPS mediated increase in neutrophil numbers is due to an 
increase in neutrophil viability since Loynes et al. reported a reduction in apoptosis 
mediated by LPS in a similar wounding model (Loynes et al., 2009). LPS induces 
inflammatory responses in fish models of inflammation (Iliev et al., 2005a, Watzke 
et al., 2007, Sepulcre et al., 2009). However whilst LPS recognition in mammals by 
TLR4 is well characterised LPS recognition in fish is poorly understood.  It has 
recently been determined that the zebrafish orthologues of TLR4 do not bind LPS 
(Sepulcre et al., 2009, Sullivan et al., 2009). Alternative receptors for LPS 
recognition in fish have been proposed, e.g."2-integrins (specifically CD11 and 
CD18) (Iliev et al., 2005b), however the receptor(s) responsible for LPS recognition 
in fish is still unknown. The underlying mechanism behind LPS mediated alterations 
in neutrophil number and dynamic behaviour will be further discussed in chapter 4 of 
this thesis.  
 
Live embryo infection models 
 
Having determined that the bacterial component LPS can amplify acute 
inflammatory responses in embryos I next developed a live bacterial infection model 
with which to investigate complex inflammatory responses including the role of p38 
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MAPK in response to infection. It is known that infection with M. marinum via 
immersion of zebrafish embryos in medium containing bacteria or by caudal vein 
injection results in granuloma formation and disseminated disease (Davis et al., 
2002a). In pilot experiments in the laboratory using caudal vein injection infections 
there was a large degree of mortality due to aggregation of the bacteria within 
vessels. I therefore chose to deliver M.marinum via the yolk sac. I demonstrate that it 
is possible to introduce M. marinum via micro-injection into the yolk sac resulting in 
the spread of the bacterium throughout the embryo and leading to death. Using a 
dsRED expressing M. marinum it was possible to follow the spread of the 
mycobacterium from within the yolk sac throughout the tissues of the embryo. This 
corresponds to the findings of Clay et al. who reported that in zebrafish embryos 
disseminated disease was mediated by the migration of infected macrophages (Clay 
et al., 2007). Macrophages anchor themselves to the underlying and overlying 
surface of the yolk sac in embryos at 2 dpf (Herbomel et al., 1999) and it is likely 
that it is these macrophages are the first to encounter the mycobacterium at the yolk 
sac. Transgenic zPu.1:EGFP embryos were used in this infection model in order to 
determine whether or not macrophages in this tissue engulf the injected 
mycobacterium. The high level of expression of GFP in the yolk sac prevented 
successful imaging of this region. However by 48 hpi dual positive cells were visible 
outside, but close to, the yolk sac. Davis et al., who inject bacteria directly into the 
blood stream, report macrophage uptake of mycobacterium as early as 1 hpi (Davis 
et al., 2002a). It is likely that the different method of infection that I selected is the 
cause of the slower appearance of macrophages that have phagocytosed the 
fluorescent bacteria. Despite the apparent delay in uptake by of bacteria by 
macrophages, when compared to the caudal vein injection route, the rate of mortality 
I observed was faster (Davis et al., 2002a). Where Davis et al. demonstrate 100% 
mortality at 9 dpi I demonstrate 100% mortality at 6 dpi following yolk sac injection. 
This acceleration in mortality perhaps reflects the injection of a greater number of 
bacterium in the initial injection. While the yolk sac may contain dissemination 
initially, by partitioning the bacteria away from the tissues, eventually when they 
become accessible to the macrophages they colonise the tissues rapidly. 
Alternatively it is possible that infected macrophages are slower to exit the yolk sac 
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disseminate throughout other tissues of the embryo as it is isolated spatially and by 
the yolk sac wall. However it is not possible to confirm this as Davis et al. do not 
provide the data required to compare the amount of bacteria introduced in the initial 
infection (Davis et al., 2002a). Furthermore there may be differences in the amount 
of bacteria introduced that would effect survival.    
 
Isolation of immune cells from adult tissue for functional and 
expression analysis 
 
Wounding alone and injury in the presence of LPS results in the recruitment 
of low numbers of cells which prevents transcriptional analysis and investigation of 
the intra-cellular mechanisms that are activated in these quantitatively different types 
of recruitment. Similarly in the embryo infection model, whilst it is possible to 
investigate whole embryo transcriptional responses to mycobacterium infection (van 
der Sar et al., 2009), the complex intracellular relationship within the mycobacterium 
containing macrophage may be lost against the background of the tissues making up 
the majority of the embryo.  I therefore attempted to isolate myeloid cells from adult 
zebrafish with a view to stimulating these cells in vitro with LPS or mycobacteria for 
analysis of functional and transcriptional responses determined in an innate immune 
cell enriched population. It was possible to isolate and sort by flow cytometry all the 
main blood lineage types from the zebrafish adult WKM (Traver et al., 2003b). I set 
out to isolate the myelomonocytes, and specifically neutrophil and macrophage 
populations in order that the functional and transcriptional responses of these 
individual cell types to LPS stimulation and M. marinum infection could be 
investigated. The flow cytometry profile produced by isolating the WKM cells was 
comparable with that of Traver et al. (Traver et al., 2003b). Discreet populations 
sorted were defined as erythrocytes, lymphocytes, myelomonocytes and precursors 
according to the morphological phenotypic classification of Traver et al. (Traver et 
al., 2003b). It was also possible to sort mononuclear phagocyte macrophage like 
cells by co-incubating WKM with GFP conjugated fluorescent beads prior to flow 
cytometric sorting of the cell suspension for uptake of beads. It was hoped that 
sorting WKM cells on phagocytic capacity would have allowed subsequent LPS 
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stimulation of M. marinum co-culture experiments with the aim of investigating the 
gene expression profiles in infected zebrafish macrophage like cells. However whilst 
the total number of cells sorted in the granulocyte containing myelomonocyte and the 
GFP positive populations was sufficient for cytospin analysis of morphology, and in 
the case of myelomonocytes for LPS stimulation for morphological activation 
experiments (see Chapter 5 Figure 24), the quantity of RNA purified from the 
myelomonocyte and GFP positive sorted populations was insufficient for 
LPS/mycobacterium stimulation/phagocytosis assays and gene expression analysis 
experiments. It was also a consideration that the functional capacity and gene 
expression profiles of the cells may have been compromised by the prolonged time 
needed to prepare and sort the cells (> 3 hours). In a compromise that shortened the 
preparation procedure but sacrificed the purity of the cell types I performed LPS 
stimulation experiments on unsorted WKM cell suspensions and in vivo coelomic 
cavity stimulations (see Chapter 4 Figure 22 and Figure 26). The WKM cells 
suspensions contained mixed leukocyte cell types, it is established from the work of 
Traver et al. that a large proportion of these cells are myelomonocytes (24%) and 
12% are neutrophils (Traver et al., 2003b). Granulocytes make up 60-80% of the 
constitutive composition of cells isolated from the coelomic cavity, as established by 
Moss and colleagues. WKM cells were used for in vitro LPS stimulation experiments 
and the coelomic cavity for in vivo LPS stimulation experiments with cells lavaged, 
post stimulation, to determine transcriptional LPS mediated effects (see chapter 3). 
So whilst I have failed to isolate adequate numbers of viable purified neutrophil and 
macrophage cells I have developed models of zebrafish leukocyte stimulation 
experiments with which to analyse the effect of LPS treatment and the role of p38 
MAPK.  
Despite the number and quality of cells sorted from WKM being too low to 
perform stimulation or co-culture experiments there was sufficient RNA purified 
from the cells to perform quantitative expression analysis of cell markers of interest 
in order to characterise the sorted cell beyond morphological phenotype. Moss et al. 
(2009) performed non-quantitative PCR on cells derived from coelomic cavity by 
sorting based on forward and side scatter. Non- quantitative PCR is only capable of 
detecting the presence or absence. Here I determined that the relative expression of 
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the myeloid lineage cell markers csf1r, mpo, and pu.1 is in agreement with the cell 
types assigned by morphological phenotyping to cell types sorted from the WKM 
and mature cells derived from the coelomic cavity lavages. Macrophage specific 
csf1r was expressed most highly in the WKM in the precursors subset. As csf1r has 
been shown to be involved in the production
 
of multiple myeloid cell lineages in 
zebrafish (Liongue et al., 2009) and is known to be expressed by early myeloid 
precursor cell types in mouse (Tagoh et al., 2002), the relative high expression of 
csf1r in cells within this gate substantiates this designation of the cells in this gate as 
precursor cells. I have shown that the relative expression of mpo is far highest in the 
sorted myelomonocyte cell population of the WKM which confirms the results of 
Hall et al. who demonstrate mpo is expressed in WKM derived myelomonocytes 
(Hall et al., 2009). Similarly the pan myeloid marker pu.1 was found to have highest 
expression within the myeloid myelomonocyte cell population with lower expression 
in the precursor population and lowest expression in the lymphocyte population of 
the WKM, which confirms the specification of different cell populations within the 
WKM by morphological phenotype.   
In the coelomic cavity derived cell fractions whilst expression of csf1r was 
higher in the macrophage/granulocyte population than the lymphocyte containing 
population as might have been expected, equivalent expression of csf1r transcript 
was also detected in the NCC and macrophage/granulocyte samples. Moss et al. also 
described expression of csf1r in all three sorted cell populations although they do not 
compare relative expression of transcripts between populations (Moss et al., 2009).  
Further to this the level of neutrophil specific mpo transcript is expressed 200 fold 
above the relative macrophage/granulocyte and lymphocyte containing populations 
strongly indicating that there are relatively more neutrophil cells within this 
population which differs from the claim that that these cells are predominantly NCCs 
derived from the lymphocyte lineage (Moss et al., 2009). Neutrophils in fish species 
are known to have killing capacity and it has been demonstrated that the number of 
neutrophils contaminating leukocyte fractions correlates with the non-specific 
cytotoxicity of those cellular fractions (Sasaki et al., 2002). Since Moss et al. 
attribute killing capacity to this NCC population, and here I find MPO most highly 
expressed in this population, it is possible that neutrophil contamination, and not the 
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presence NCC marker expressing cells, is responsible for the increased killing. 
Furthermore the killing capacity experiments performed by Moss and colleagues in 
which zebrafish coelomic cells were tested against NK cell targets used whole 
coelomic cavity cell fractions and not sorted fractions. They do not show definitively 
that the cells expressing NCC markers are responsible for the killing capacity. 
Further evidence of a contamination of myeloid cells within the NCCs fraction is 
provided with the relative high expression of the early myeloid marker pu.1 in the 
macrophage/granulocyte and NCC populations versus the lymphocyte population. 
 
The purpose of developing these different models of inflammation in 
zebrafish embryo and adult cellular assays was to produce systems in which the 
evaluation of the effects of p38 MAPK inhibition and Notch signalling defects on 
immune responses was possible.  This aim has been achieved and the effect of 
inhibition of p38 MAPK in these model systems will be investigated in the following  
chapter.   
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Chapter 4. LPS induced modulation of leukocyte migration to 
wound injury is p38 MAPK dependent.  
 




The principle aims of the experiments reported in this chapter were: 
• To use the zebrafish models characterised in chapter three to investigate 
the role of p38 MAPK in inflammation.  
• To use in vivo time lapse imaging in the tail injury model of cell 
recruitment (see chapter three) to develop computational single cell 
tracking in transgenic zebrafish embryos and to characterise the effect of 




Having determined that LPS enhances the number of cells recruited to wound 
injury these experiments were extended to investigate potential effects of inhibiting 
p38 MAPK on leukocyte recruitment and migration in this system. In order to 
achieve this I developed, with my colleague Juliane Liepe who carried out the 
computational analyses of the biological data, a system of automated single cell 
tracking to determine the dynamical characteristics of single cell 
movement/migration to wound injury. Current models of single cell tracking in vivo 
either require invasive surgical procedures to gain access to tissues at high 
magnification or available non-invasive methods require specialized equipment, 
either multiphoton microscopes or MRI scanners working at high magnetic fields. 
Multiphoton imaging uses two-photon microscopy, which is capable of imaging 
living tissue up to a depth of one millimeter. It was first used to image 
 
   88 
immunological interactions in 2002 (Bousso et al., 2002, Miller et al., 2002, Stoll et 
al., 2002). These recent developments in real-time imaging analysis of the dynamics 
of single cells are advancing our knowledge of single cell interactions in the immune 
response. Miller et al. (Miller et al., 2002) first used novel microscopic techniques to 
image single cell interactions in real time within explanted mouse lymph nodes. 
Antigenic challenge of T cells resulted in the switch from random walk movement to 
a “swarming” phenotype (Miller et al., 2002). Dynamic cell imaging has been 
applied to demonstrate T-cell activation and migration following an antigenic 
stimulus (Stoll et al., 2002). Advances following these initial studies, which imaged 
cell interaction in explanted tissue, allowed in vivo deep tissue imaging of cell-cell 
interactions (Halin et al., 2005).  Recently Rosenbaum et al. used video-microscopy 
to characterize T-cell and APC interaction in inflamed tissue for the first time using 
intravital microscopy in the iris (Rosenbaum et al., 2008). The data acquisition step 
in this intravital imaging technique is limited by movements of the eye, including eye 
rolling and pupil contractions, as well as by movements caused by animal breathing 
and videos must be stabilized computationally after acquisition. Real time in vivo 
cell imaging is important in understanding cellular interactions within the immune 
system in order to gain understanding of disease processes. 
Zebrafish and medaka embryos have been used in several studies to 
automatically track the migration of leukocytes to acute wounding in vivo (Grabher 
et al., 2007, Redd et al., 2006). These studies have used existing imaging software 
programs to design their tracking systems (Redd et al., 2006, Grabher et al., 2007) 
and do not correct for typical tracking errors as outlined by Beltman et al. in a recent 
review (Beltman et al., 2009). Common artifacts include “switching” (cells overlap 
and it is difficult for the algorithm to determine one cell from the other when they 
separate), “double tracking” (algorithm can designate a long or stretched cell as two 
cells instead of one) and “border tracking” (cells near the edge of the field of view’s 
positions are estimated wrongly).“Switching” and “double tracking” errors can be 
corrected by manually viewing suspect tracks. “Border tracks” should be excluded 
from analysis (Beltman et al., 2009). Here I report a novel automated cell tracking 
system that takes into account recent advances in the avoidance of cell tracking 
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errors and extends and improves upon previous models of automated cell detection 
and tracking in vivo.  
Transparent transgenic zebrafish expressing GFP under leukocyte specific 
markers were used to produce time-lapse image sequences of the leukocyte response 
to acute injury. A system of computational automated cell tracking was designed 
with which the time-lapse biological data can be processed to analyse the dynamical 
migration of leukocytes to acute injury at the single cell level. 
It has been reported that LPS can induce the expression of inflammatory 
cytokines (Watzke et al., 2007) and mortality at high concentrations (Novoa et al., 
2009) in zebrafish embryos. LPS enhances human neutrophil migration via the 
activation of p38 MAPK (Aomatsu et al., 2008) and I have demonstrated that LPS 
enhanced neutrophil recruitment to tail wounding in zebrafish embryos (Figure 4, 
Figure 5 & Figure 6 in chapter 3). LPS is also known to induce inflammation via the 
activation of p38 MAPK and in this chapter I investigate the role played by p38 
MAPK in the LPS enhanced leukocyte migration to acute wound injury.  
Here I describe an in vivo model that uses time-lapse imaging in conjunction 
with a novel automated mathematical method of cell detection to track and analyze 
leukocyte recruitment to damaged tissue. The effect of LPS stimulation on the 
number and directionality of recruited leukocytes is tested and to what extent any 
LPS mediated effects are dependent on the action of p38 MAPK was investigated.  
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Results 
 
Development of automated single cell tracking system 
 
Time lapse image acquisition of zpu.1:EGFP transgenic zebrafish embryos 
(which express EGFP under the myeloid specific Pu.1 promoter (Hsu et al., 2004)) at 
5 dpf was used to record the recruitment of leukocytes, i.e. PU.1
+
 cells, to a wound 
produced by tail transection. The development of a computational automated cell 
tracking and detection system (developed in collaboration with Juliane Liepe) 
allowed me to extract information from many films in a short time (Figure 14). The 
software takes into account typical tracking errors, recently documented by Beltman 
et al. (Beltman et al., 2009), and minimizes them resulting in more reliable trajectory 
data. Figure 15 and Figure 16 are image sequences that demonstrate the ability of the 
automated single cell tracking system to detect multiple single cells (cells shown in 
red) within a wounded tail and track their movement over time (blue trajectory lines).  
 
Leukocyte cell migration dynamics are spatially dependent  
 
A time frame of 2-4 hpi was selected for analysis of dynamic behaviour as 
kinetic experiments  (Figure 3 & Figure 18) had identified this period as optimal for 
cell recruitment. The kinetics of single cell migration to the injured zebrafish tail was 
captured using time-lapse microscopy and data processed to extract trajectory 
information for each leukocyte. I observed, from the extracted trajectory data, cells 
that performed either a directed movement or showed random walk characteristics. 
Several random walk aspects were analysed, including the directionality coefficient, 
isotropic behaviour and the distribution of projected step sizes onto the axis parallel 
to the wound (X direction) and parallel to the blood vessels (Y direction) (see 
material and methods for details). Cells that moved between the blood flow and the 
wound site showed a more directed movement than cells at the wound and cells more 
distant from the wound (Figure 17). This suggests a spatial-temporal gradient-
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mediated dependency of leukocyte dynamics. Cells located between the blood flow 
and the wound displayed a biased random walk, i.e. they showed directed movement 
along the Y-axis but had a tendency to display random walk characteristics along the 
X- axis.  
 
LPS enhances leukocyte recruitment and/or retention following tail 
transection in a p38 MAPK-dependent fashion 
 
This experimental platform enables the screening of large numbers of 
embryos at the single cell level to determine the effect of modulators of cell 
migration. In chapter three I observed LPS enhanced the number of neutrophils 
recruited to acute injury (Figure 4, Figure 5 &Figure 6, chapter 3). Using the 
automated cell tracking system the effect of LPS on the level of immune cell 
recruitment was analysed. It was observed that the presence of bacterial components 
increased the number of cells observed at the site of injury. Immersion of embryos, 
wounded by tail transection, in LPS (10 µg/ml) increased the number of Pu.1
+
 cells 
found at the injury site. This effect was observed over the entire period of the 
experiment (Figure 18). Pu.1
+
 cell numbers around an un-stimulated injury site 
peaked at 5 hpw, the number of cells decreasing thereafter (Figure 18); these results 
are consistent with data from earlier experiments (Figure 3 & Figure 6) and those of 
other workers (Renshaw et al., 2006). I next determined the effect of a 
pharmacological inhibitor of the p38 MAPK signalling pathway, SB203580, on the 
migration process. Although no effect of the inhibitor on the number of leukocytes at 
an un-stimulated wound site was observed, SB203580 completely abrogated the 
LPS-mediated enhancement of cell recruitment and retention (Figure 18). The 
temporal profile of cell migration remained identical across treatment groups, 
irrespective of the presence or absence of either LPS or SB203580, i.e. there was no 
observed delay in recruitment or shift in time of the peak in recruitment only an 
overall increase in cell number. 
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LPS-enhanced directionality of movement is p38 MAPK dependent 
 
In the next set of experiments the influence of LPS on single cell migration 
dynamics was investigated. The directionality coefficient was calculated as well as 
the proportion of Pu.1
+
 cells showing a random walk for untreated and LPS treated 
wounds. The average directionality coefficient in response to LPS is 0.40 and is 
significantly higher compared to untreated groups (wound alone 0.30, +SB2030580 
0.27, LPS + SB2030580 0.31), demonstrating that cells move in a more directed way 
through the extracellular matrix in the presence of LPS than an untreated wound 
(Figure 19 A). Random walk characteristics are suppressed in the LPS treatment 
response compared to the wound only (Figure 19 B-C). A more detailed study of the 
trajectories reveals that the changes are not equivalent on X and Y-directions (Figure 
19 C-D). Even in the presence of LPS some leukocytes still perform a random walk 
in the direction parallel to the injury (X-direction), i.e. perpendicular to the target 
direction (Figure 19 D). The effect of LPS on the dynamics is reversed when the 
embryos are treated with SB2030580 (Figure 19). Note that an effect of LPS or 
SB2030580 on the average speed of the Pu.1
+
 cells (Figure 20) could not be detected. 
 
LPS induces p38 MAPK dependent enhanced neutrophil recruitment to 
wound injury in a fixed embryo model 
 
Having determined p38 MAPK dependent LPS enhancement of leukocyte 
cell number to tail transection injury over time in zEGFP:Pu.1 transgenic embryos 
(Figure 16) I performed experiments to validate this effect in WT embryos and to test 
that the LPS effect was not limited to the E. coli strain of LPS. WT embryos were 
wounded by tail nick or tail transection and stained for the neutrophil marker MPO. 
Both E. coli and S. enterica derived LPS induced enhanced neutrophil 
recruitment/retention to wound injury in fixed and MPO stained WT embryos at 5 
(dpf). Immersion of embryos wounded by either tail transection of tail nick injury in 
either E.coli or S.enterica LPS significantly enhanced neutrophil recruitment to an 
acute injury by 40% (P<0.001) and 50% (P<0.001) respectively in tail transection 
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injuries and 50% (P<0.001) and 65% (P<0.05) in tail nick injuries respectively 
(Figure 21 A-D). In the presence of SB203580 the E. coli LPS mediated 
enhancement of cell migration was reduced significantly to the level of that in the 
untreated sample for both the tail transection (P<0.01) and the tail nick injury models 
(P<0.01)  (Figure 21 A-D). Salmonella LPS mediated enhancement of cell migration 
was reduced to levels of that in the untreated group in tail transection (P<0.01) and 
the tail nick injury wounds (Figure 21 A-D). SB203580 had no effect on the baseline 
levels of neutrophil recruitment in embryos with wound alone in both the tail 
transection and the tail nick injuries (P>0.01). These results measured in fixed and 
stained embryo tissue demonstrate that LPS from two different source organisms 
causes increases in recruitment/retention of neutrophils and is in agreement with the 
p38 MAPK dependent LPS enhancement in recruitment/retention seen in the live 
recruitment automated cell tracking system (Figure 18). 
 
LPS induction of cytokine expression in coelomic cavity cells in vivo 
varies greatly between animals 
 
As discussed in the previous chapter the low numbers of leukocytes recruited 
to wound sites in embryo injury models limits transcriptional analysis of the gene 
expression changes occurring in response to LPS and SB203580 at sites of injury. I 
have shown that it is possible to derive cells from coelomic cavity lavages and 
perform quantitative PCR to determine relative expression of lineage markers 
(Figure 13 chapter 3). Therefore using this in vivo coelomic cavity approach LPS 
stimulations were performed in order to determine transcriptional responses and to 
investigate the role of p38 MAPK in LPS induced changes in gene expression. p38 
MAPK was first identified as a protein critical for production of the cytokines IL-1 
and TNF in human monocytes in response to LPS (Lee et al., 1994) and was 
subsequently shown to be required for LPS induced IL-10 expression in human 
macrophages (Ma et al., 2001). The primary aim of these experiments was to 
confirm that in zebrafish, as in mammals, LPS induces the expression of cytokines 
via the action of p38 MAPK. Consequently zebrafish tnfa, il-1, and il-10 genes were 
chosen for qPCR expression analysis in order to test the ability of LPS to induce 
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expression of genes predicted to be regulated by p38 MAPK. LPS induced cytokine 
expression in adult in vivo coelomic cavity cell stimulation experiments (Figure 22). 
Increases in the expression of tnfa (7, 8 and 42 fold),  il-1b (6, 7 and 58 fold) and 1l-
10 (5, 24 and 10 fold) were observed in the coelomic cavity cells isolated from 3 
different LPS stimulated adult fish (Figure 22). LPS stimulation of coelomic cavity 
cells in vivo induced expression of these cytokines in all fish tested, however the 
level of induction varied greatly between the three animals. There was variation in 
the fold induction induced by LPS stimulation between fish. This was most likely 
caused by the high level of genetic variation in laboratory strains of zebrafish which 
is known to be greater than the genetic variation of other laboratory strains of 
animals (Guryev et al., 2006). 
 
LPS induces expression of tnf in adult WKM but not embryo tissue 
 
It was also possible to investigate the transcriptional response of zebrafish 
immune cells to LPS in adult zebrafish WKM derived cells. In this case by pooling 
WKM cells derived from a several adult fish before subjecting them to treatments in 
vitro it was possible to eliminate the inter-fish variation in LPS responsiveness 
observed in the coelomic cavity experiments. LPS induced tnfa expression in adult 
WKM derived cells in a dose dependent fashion with maximal induction of 
expression achieved at a concentration of 50 µg/ml, resulting in a 10 fold increase in 
transcript when compared to the untreated sample (Figure 23). Phorbol myristate 
acetate (PMA) was used as a positive control and increased tnfa transcript 70-fold 
(Figure 23). 
Having determined that, as in mammals, zebrafish leukocytes respond to LPS 
stimulation with cytokine production, I then determined whether LPS induced 
responses were detectable in zebrafish embryos. The expression of tnfa in untreated 
embryo tissue relative to untreated adult WKM cells was tested. Relative to untreated 
embryos, resting adult WKM expressed higher (>300 fold) levels of tnfa transcript 
(Figure 23). Exposure of embryos to increasing concentrations of LPS (1 – 150 
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µg/ml) failed to induce tnfa expression, although gene expression was elevated (2 
fold), albeit minimally in response to PMA treatment (Figure 23).  
 
LPS mediated morphological activation of myeloid cells is absent in 
zebrafish 
 
In order to compare the functional responses of zebrafish leukocytes to LPS 
stimulation with classical mammalian activation responses, and to confirm the 
biological activity of the E. coli LPS used in all stimulation experiments, I performed 
morphological activation assays in vitro on human neutrophils and zebrafish myeloid 
cells. Zebrafish sorted myelomonocytes (zMyelomonocytes), which are largely 
composed of granulocytes (Traver et al., 2003a), stimulated with LPS showed no 
change in morphology whilst human neutrophils displayed activated cell morphology 
(adhesion and cell spreading with the formation of distinct lamellopodia). Both 
zebrafish myelomonocytes and human neutrophils displayed activated morphologies 
in response to stimulation with PMA, demonstrating the zMyelomonocytes did have 
the capacity for morphological activation (Figure 24).   
 
SB203580 inhibits phosphorylation of p38 MAPK in zebrafish embryos 
  
The amino acid sequence of the activation site of the p38 MAPK protein is 
conserved between zebrafish and mammals (Krens et al., 2006). Consequently 
activated zebrafish p38 MAPK can be probed for using antibodies produced against 
the mammalian phosphorylated p38 (pp38). To determine the ability of p38 MAPK 
inhibitor SB203580 to modulate the activation of p38 in zebrafish, embryos were 
treated with LPS and SB203580 and the protein extracted for western blot analysis of 
p38 activation. Unstimulated WT embryos at 4 dpf have significant levels of 
activated pp38 protein (Figure 25 B and D). Stimulation of embryos with LPS did 
not increase detectable pp38 (Figure 25 B). Exposure of LPS stimulated embryos to 
both 10 and 100µM SB203580 resulted in a reduction in pp38 (Figure 25 B and D). 
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LPS induces cytokine expression in WKM cells in vitro via the action of 
p38 MAPK 
 
 LPS induced cytokine expression in adult WKM can be suppressed by the 
action of p38 MAPK inhibitor SB203580 (Figure 26). LPS induced a 10 fold 
increase in tnfa expression that was suppressed to levels of the DMSO treated sample 
in the presence of SB203580. Lymphotoxin alpha (LTA) is a member of the TNF 
family of ligands and receptors and was recently identified in zebrafish by Savan and 
colleagues (Savan et al., 2005) and its gene expression is assayed here in parallel 
with tnfa. LPS induced a 10 fold increase in lta expression that was suppressed to a 4 
fold induction on treatment with SB203580. LPS induced a 7 fold increase in il1b 
expression that was suppressed to a 2 fold induction treated sample in the presence of 
SB203580 (Figure 26). A PI stain was performed on WKM cells after four-hour 
incubation with DMSO or SB203580. The SB203580 treated sample showed a small 
increase (5-9%) in cell death when compared with the DMSO sample demonstrating 
that cell death was not the cause of the reduction in cytokine production.  
 
LPS induces expression of chemokines via the action of p38 MAPK 
 
Migration of cells through tissue requires the cells to follow chemotactic 
gradients. A recent genetic survey in zebrafish has revealed many potential 
orthologues of well-studied mammalian chemokines (Nomiyama et al., 2008) and I 
investigated whether the expression of any of these zebrafish chemokines was 
regulated by treatment with LPS or SB203580. Transcriptome profiling of zebrafish 
embryonic responses to salmonella infection revealed induction of expression of 
zebrafish cxcl8 (il-8) and cxcl-C1c (Stockhammer et al., 2009) . Several investigators 
have also shown that il-8 expression/protein release is regulated by p38 MAPK 
(Bhattacharyya et al., 2002, Ostrowska and Reiser, 2008, Li et al., 2009, Marie et al., 
1999). The chemokine CXCL12 (also known as SDF-1) is known to be highly 
chemoattractive for lymphocytes (Bleul et al., 1996) and the zebrafish orthologue of 
this gene cxcl12a is known to be expressed in embryo tissue (David et al., 2002). For 
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these reasons I selected to assay the expression of the il-8, cxcl-C1c and cxcl12a 
chemokine genes in WKM cells treated with LPS and SB203580. LPS induced 
zebrafish il-8 and cxcl-C1c chemokine expression in adult WKM cells resulting in 5 
and 3 fold increases in transcripts, respectively. SB203580 alone had no effect on 
expression of il-8 and cxcl-C1c when compared with the DMSO control samples. 
Treatment with LPS and SB203580 suppresses LPS induced expression of il-8 by 
40% and of cxcl-C1c by 60%. There was no change in the chemokine cxcl12a across 
all treatment groups (Figure 27).  
 
Effect of SB203580 on infection with M. marinum 
 
Since SB203580 has a functional effect on leukocyte migration, cytokine 
production and chemokine production in zebrafish I hypothesised it may have 
affected survival of embryos infected with M. marinum. Embryos were injected with 
PBS or M. marinum, as described in the materials and methods section, then 
immersed in either system water containing either DMSO or SB203580 and 
incubated for several days. To control for the effect of long-term immersion of 
embryos in SB203580 embryos injected with PBS alone were exposed to the 
inhibitor for several days. The long term exposure to the inhibitor proved toxic to the 
embryos and prevented further exploration of the effect of the inhibitor on M. 
marinum infected embryos (data not shown). 
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Figures 
 
Figure 14. Bright field image of an injured zebrafish tail labels demonstrating data 
normalization and data analysis. In all generated movies the zebrafish were injured 
via tail transection so the injury is located orthogonal to the blood vessels. For 
analysis of data extracted from different movies they were normalized. Linear 
transformation of the trajectory data results into the new axes shown in red. The 
image resolution was constant in all movies. Scale bars are 100 µm (A). Microscopy 
image showing fluorescent Pu.1:eGFP leukocytes (B). The white line indicates the 
shape of the cells that have been detected using an automated image-processing 
algorithm and scale bars are 20 µm (B). An example trajectory (blue) would be 
tested for random walk characteristics. Two chosen motion vectors v1 and v2 (red) 
with their projections onto the x-axis and the y-axis (x1, y1 and x2, y2) are used to test 
for isotropy. Therefore the angle ! between v1 and v2 was calculated. If the random 
walk model holds, the one-dimensional projections of the motion vectors onto the 
axes are Gaussian distributed (C).
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Figure 15. Time-lapse bright field images overlaid with images of Pu.1
+
 cells 
automatically detected (red cells) and tracked (blue trajectory lines) produced by 
automated single cell tracking system in a zebrafish zPu.1eGFP embryo wounded 
with tail transection. Time starts from 3 hpw and images shown are at 60 sec 
intervals (original time gap between images used for data analysis was 15 secs).  
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Figure 16. Time-lapse bright field images overlaid with images of single Pu.1
+
 cell 
automatically detected (red cell) and tracked (blue trajectory line) produced by 
automated single cell tracking system in a zebrafish zPu.1eGFP embryo wounded 
with tail transection. Time starts from 3 hpw and images shown are at 30 sec 
intervals (original time gap between images used for data analysis was 15 secs). 
 




Figure 17. Leukocyte dynamical behaviour is dependent on the location of the cells 
in the organism. The detected trajectories extracted from all movies of untreated 
zebrafish are shown. Trajectories have been clustered according to their average 
distance to the wound in five groups and each of them is represented in a different 
colour. For each group the average directionality coefficient (right barplot) and the 
proportion of cells showing a random walk (RW-Y) (left barplot) is computed. Both 
dynamical properties show a dependence on the distance from the wound. Scale bars 
are 100 µm. 
 
   102 
 
 
Figure 18. LPS treatment enhances recruitment of myeloid cells to a tail transection 
wound in zpu.1:EGFP zebrafish embryos (5 dpf). Embryos were wounded then 
immersed in system water or system water containing E.coli LPS (eLPS, 055:B5) at 
10 µg/ml in the absence or presence of SB203580 at 10 µM (+/- SB) and incubated 
for 2 hours before being transferred into agar and imaged microscopically. 
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Figure 19. LPS enhanced directionality of cells can be ablated in the presence of p38 
MAPK specific inhibitor SB203580. The directionality coefficients for each 
trajectory detected under one of the 4 described conditions. The lines indicate the 
expected values. The box indicates the 95% bootstrap confidence interval of the data 
distributions. The expected value of the directionality coefficient under LPS pressure 
is significantly higher compared to the remaining 3 conditions (A). Analysis of 
random walk (RW) aspects. The proportion of leukocytes that show one of the 
random walk aspects (isotropy of angles between two consecutive motion vectors is 
shown (B), Gaussian distribution of the projection of the motion vectors onto the y-
axis (C) and x-axis (D), respectively) in respect to the total number of leukocytes 
detected (* represents P>0.05, ** represents P>0.01 and *** represents P>0.001, 
computed with a randomized permutation test).
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Figure 20. The average velocity of PU.1
+
 cell trajectories is not LPS dependent. 
zPu.1:eGFP embryos were wounded then immersed in E.coli LPS (eLPS) at 10 
µg/ml in absence or presence of SB203580 at 10 µM (+/- SB203580). Error bars 
show the standard deviation. No significant differences were detected. 
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Figure 21. LPS treatment enhances recruitment of neutrophils to tail transection (TT, 
A & B) and tail nick (TN, C & D) wounds. Embryos at 5 dpf were wounded then 
immersed in E.coli (eLPS, 055:B5) or S. enterica (sLPS) LPS at 1 µg/ml in absence 
or presence of SB203580 at 10 µM (+/- SB) and at 4 hours (TT) or 2 hours (TN) post 
injury were killed, fixed and histochemically stained and scored for MPO positive 
cells at wound site (* represents P>0.05, ** represents P>0.01 and *** represents 
P>0.001). Bar graphs and dot plots represent the same data but showing individual 
data points for tail transection data (A & B) and tail nick data (C & D). Data were 
analysed using non-parametric one-way variance analysis (ANOVA) test with 
Dunn’s multiple comparison post-hoc, Mann-Whitney test. Error bars shown are 
95% confidence intervals. The experiments presented are representative of &  3 
performed.
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Figure 22. Quantitative PCR analysis of expression of zebrafish tnfa, il-1b, and il-10 
cytokine expression in adult coelomic cavity cells. Three adult WT fish had coelomic 
cavity flushed for cells at time zero and the cells lysed for RNA. LPS (10 µg/ml 
serotype 055:B5 in PBS) was injected into the coelomic cavity of each of the adult 
fish and after 4 hours coelomic cavity lavages were performed to isolate LPS 
stimulated cells which were lysed for RNA. RNA was processed to cDNA and 
taqman qPCR performed to assay gene expression. Gene expression is normalised to 
18S and is presented as fold change relative to expression of the un-stimulated cells 
taken from each fish analysed. Bars represent expression of coelomic cavity cells 
from 1 animal.  
 




Figure 23. Quantitative PCR analysis of expression of zebrafish tnfa expression in 
adult WKM and embryo tissue. Stimulation with various concentrations of LPS 
(serotype 026:B6) or PMA (at 10ng/ml) was performed on WKM cells extracted and 
pooled from 10 adult fish and >25 embryos at 5 dpf and the tissues processed for 
cDNA. Gene expression is normalised to ef1-! and is presented as relative to the 
mean of the unstimulated sample (A & C). Graphs are representative of & 3 
experiments performed.  
A B C 
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Figure 24. LPS induces change in cell shape of human neutrophils (hNeutrophils) 
but not zebrafish sorted myelomonocytic cells (zMyelomonocytes). Human 
neutrophils or zebrafish myelomonocytes were untreated or stimulated with E.coli 
LPS (serotype 055:B5, 1 µg/ml) or PMA (10 ng/ml) and visualised at 0.5 hrs. The 
images are representative of 3 experiments performed. 
 
 







Figure 25. Western blots showing pp38 protein levels in 4 dpf embryos either 
untreated (control 1% DMSO), exposed to LPS (10 µg/ml) and LPS + SB203580 (at 
10 or 100 µM as indicated) (B & D). The ponceau red stain for total protein is 
presented as a loading control (A & C). 
 






  % cells FL-2 positive 
Treatment WKM1 - PI WKM2 + PI 
DMSO 24.1 22.7 
SB203580 33.8 27.5 
 
Figure 26. Quantitative PCR analysis of expression of zebrafish cytokine expression 
in adult WKM tissue. WKM cells extracted from adult fish were stimulated with LPS 
(serotype 055:B5 at 10µg/ml) and/or SB203580 (10µM) and the tissues processed 
for cDNA. Gene expression is normalised to 18S and is presented as relative to the 
mean of the un-stimulated sample. Graphs represent expression of kidneys from one 
WT fish and are representative of at least 3 experiments performed (A). Table 
showing percent propidium iodide (PI) positive cells in WKM cells from two fish 
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Figure 27. Quantitative PCR analysis of expression of zebrafish il-8, cxcl-C1 and 
cxcl12a chemokine gene expression in adult WKM tissue. WKM cells extracted and 
pooled from adult fish were stimulated with LPS (serotype 055:B5 at 10µg/ml) 
and/or SB203580 (10µM) and the tissues processed for cDNA. Gene expression is 
normalised to 18S and is presented as relative to the mean of the un-stimulated 
sample. Graphs are representative of 3 experiments performed. 
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Discussion 
 
In this chapter I have used data produced from time-lapse imaging of 
leukocyte recruitment to acute injury along with a novel computational system of 
automated single cell tracking injury to demonstrate LPS enhanced cell 
migration/retention behaviour is p38 MAPK dependent. 
 
Leukocyte cell migration dynamics are spatially dependent  
 
Those leukocytes located closest to the wound and those furthest away 
displayed similar random walk and directionality behaviour with these cells 
displaying a lower tendency towards directed movement and a higher tendency 
towards random movement at these positions. Cells located at an intermediate 
position, i.e. trafficking towards and away from the wound site, displayed more 
directional and less random behaviour.  The observed decrease in random walk-like 
behaviour at intermediate distances might reflect the interplay between a signalling 
gradient and the leukocyte chemotactic machinery, which leads to directed 
movement towards the source of the signal. Niethammer et al. have reported that 
leukocyte migration during acute inflammation is dependent on the presence of an 
H2O2 gradient (Niethammer et al., 2009). This gradient reaches up to 300 µm from 
the injured tail into the surrounding tissue and in this area the highest directionality 
coefficient was detected in leukocytes tracked. Once the leukocytes reached the 
injury and therefore the region of the highest H2O2 concentration, they exhibited 
“tumbling” behaviour. The increased number of trajectories showing a random walk 
behaviour located at greater distance to the wound could be explained by a low or 
absent H2O2 signal. Several cells migrated backwards from the wound towards the 
blood vessels, consistent with previous reports of retrograde leukocyte chemotaxis 
(Mathias et al., 2006, Hall et al., 2007). Whilst substantial progress has been made in 
understanding the complex molecular factors that orchestrate the movement of 
leukocytes from the vasculature into tissues less is known about the active movement 
of leukocytes back towards the vasculature. This migration of cells from the tissues 
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toward the vasculature is known as reverse chemotaxis and was recently reviewed by 
(Huttenlocher and Poznansky, 2008). It is reported that neutrophil chemoattraction or 
chemorepulsion behaviour on exposure to IL-8 (cytokine-induced neutrophil 
chemoattractant-1, CINC-1) is dependent on the concentration of IL-8 (Tharp et al., 
2006). Tharp and colleagues demonstrated in vitro (human neutrophils) and in vivo 
(rat neutrophils) that at low concentrations of IL-8 neutrophils were attracted and 
moved up the gradient of chemokine, however at increasing concentrations 
neutrophils changed behaviour and were repulsed, moved down the gradient (Tharp 
et al., 2006). The mechanisms underlying bi-directional migration of neutrophils in 
zebrafish are not yet known and reverse chemotaxis of neutrophils in mammalian 
systems has not yet been clearly shown. Huttenlocher and colleagues propose two 
possible mechanisms for reverse migration of neutrophils in the zebrafish injury 
model, competing chemoattractive gradients or the contribution of both chemokinetic 
and chemorepulsive agents at the wound site (Huttenlocher and Poznansky, 2008). 
Here I have shown that the regulation of zebrafish il-8 gene expression in zebrafish 
immune cells in vitro by LPS and the inhibitor SB203580 correlates with p38 MAPK 
dependent LPS enhanced migration of immune cells, suggesting a role for zebrafish 
IL-8 in the complex chemotactic control of neutrophil migration.  
 
LPS enhances recruitment/retention and the dynamical behaviour of 
leukocytes in a p38 MAPK-dependent fashion 
 
I have shown LPS increases the number of myeloid (Pu.1
+
cells) (Figure 18) 
recruited and/or retained to an injury over time. There are more cells at the wound 
site in LPS treated embryos which is in agreement with the findings of Loynes et al. 
(2009) who report a reduction in apoptosis mediated by LPS (see Figure 28).  
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Figure 28. Adapted from Loynes et al. (2009). LPS (highly purified bacterial LPS 1 µM 
Alexis Pharmaceuticals, San Diego, CA, USA) induces inhibition of neutrophil apoptosis 
which is associated with a defect in resolution of the cellular component of the inflammatory 
response following tissue injury in the zebrafish. Three dpf mpx:GFP zebrafish embryos were 
injured by tail transection  and count of neutrophils at the sites of injury were made at 6 and 
24 hpw. For each fish the percentage reduction in neutrophil numbers between these 
timepoints was calculated a measure of the percentage resolution of the neutrophil 
component of the inflammatory response.  
 
However if delay/inhibition of apoptosis were the single cause of the observed 
increased cell number I would expect to observe a delay in resolution of recruitment 
leading to higher cell number over time (Loynes et al., 2009). What is actually 
observed is an increase in cell number across the whole time course but no changes 
in the kinetic of the resolution of inflammation. This is perhaps best illustrated in a 






Schematic 8. Schematic demonstrating the observed curves (Figure 18) – LPS 
(blue line) and + LPS (red line) and the predicted curve + LPS if inhibition of 
apoptosis alone were responsible for the increase in cell number (red dashed line).  
 
If inhibition of apoptosis were the only factor responsible for the elevated 
number of cells at the wound a delay in resolution of recruitment would be expected 
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observed is elevated numbers of cells across the whole time course but no change in 
the curve, no delay in the rate of resolution of the recruitment. Loynes et al. 
examined a longer and later time period after injury, it is possible that at later time 
points inhibition of apoptosis is the primary reason for elevated cells at the LPS 
treated wounds. During time period following the peak in resolution there is no delay 
in the resolution of the inflammation, and there are elevated cell numbers in the LPS 
injuries even before the peak in recruitment, suggesting it is necessary to look 
beyond cell number and consider cell behaviour to determine the underlying reasons 
for elevated cell number. Specifically the random walk and directional behaviour of 
these cells was analysed and it was found that LPS induced changes in the migratory 
behaviour of cells, which may explain the higher number of leukocytes observed at 
the wound site across the experimental period.  
In order to determine the underlying mechanism of the elevated numbers of 
cells at the LPS exposed wound site the trajectory data for each single cell recruited 
was processed and measures of dynamic behaviour were quantified. This revealed 
that those cells exposed to LPS displayed a more directed movement and fewer cells 
displayed random walk behaviour when compared with untreated cells. This in vivo 
finding extends the observation of Aomatsu et al. who demonstrate in vitro that 
human neutrophils migrate in a random pattern and on LPS treatment display 
directed migration when the cells are further challenged with gradient concentrations 
of chemo-attractants (Aomatsu et al., 2007). Furthermore, it has been reported that 
human granulocytes in vitro conform to random-walk theory and on addition of 
bacteria to these cultures they no longer do so (Peterson and Noble, 1972). Since we 
observe no increase in the speed of migration on treatment with LPS we can exclude 
the possibility that faster recruitment to the wound is responsible for the increase cell 
number at injury. The ability of LPS to induce more directed and less random 
behaviour in leukocytes provides an alternative explanation to inhibition of apoptosis 
as the underlying cause of higher cell number at wound site. If the tendency of cells 
towards directed movement is increased by LPS then it is reasonable to assume that 
more cells would find their way to the wound site resulting in higher cell counts over 
the course of the inflammatory response to injury.  
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I have shown not only that the LPS mediated increase in the number of 
neutrophil and PU.1
+
 cells recruited to injury but that this increase is p38 MAPK 
dependent. These in vivo findings extend the observations that increased migration of 
human neutrophils in vitro is induced by LPS activation via the action of p38 MAPK 
(Aomatsu et al., 2007), and TNF!-primed human neutrophil migration to chemokine 
is p38 MAPK dependent (Montecucco et al., 2008). The finding that the p38 MAPK 
inhibitor had no effect on the baseline levels of cell recruitment in fish with un-
stimulated wounds is consistent with observations of Zhang et al. (Zhang et al., 
2008), who find that migration of primitive zebrafish macrophages is mediated by 
JNK but not p38 MAPK, and suggests that there are two different pathways 
responsible for basal and LPS-induced recruitment. A hydrogen peroxide (H2O2) 
gradient is required for leukocyte recruitment to tail fin injury (Niethammer et al., 
2009) and since p38 MAPK is activated in the downstream signalling response to 
H2O2 stimulation (Guyton et al., 1996), I might have expected that SB203580 would 
have had an inhibitory effect on recruitment in wound injury alone. However, this 
was not the case, suggesting that p38 MAPK is only required for the LPS-enhanced 
component of cell migration.  
 
SB203580 as well as ablating LPS enhanced recruitment of cell number to 
injury was capable of ablating the LPS mediated effect on directionality and random 
walk behaviour. Hannigan et al. demonstrated that neutrophils deficient in Mitogen-
Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2), which is a 
direct downstream target of p38 MAPK, showed a partial loss of directionality but an 
increase in migration speed (Hannigan et al., 2001). Our results support a role for 
p38 MAPK in the shift of leukocytes to a directed movement however we observed 
no change in the speed of the migration on exposure to SB203580. Neither LPS nor 
SB203580 treatments had an effect on the speed with which the cells migrated 
suggesting that the larger inflammatory reaction results only from a larger number of 
recruited/retained cells, which migrate with increased directionality towards the 
injury. The suggested role for the p38 pathway in the in vitro study of Hannigan et 
al. study is supported by the finding of this study that the increase in the 
directionality coefficient of recruited leukocytes under LPS stimulation in live 
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embryos is p38 MAPK dependent. The in vivo results here go beyond these in vitro 
studies and demonstrate that leukocyte recruitment to an un-stimulated wound is 
unchanged by the inhibition of p38 MAPK but that the enhanced directionality and 
recruitment of these cells to the injury when challenged with the LPS is dependent on 
the action of p38 MAPK.  
 
LPS induces expression of cytokines via the action of p38 MAPK 
 
Here I report intra-coelomic injection of LPS resulted in induction of 
cytokine expression in coelomic exudate cells. This result extends the findings of 
Moss and colleagues who demonstrated that LPS injected into the coelomic cavities 
of adult zebrafish induced immune cell influx as it does in mammalian models of 
peritonitis (Moss et al., 2009). However I noted there was considerable variation in 
level of induction of cytokine and contributing to this is the extensive genetic 
variation within laboratory strains of zebrafish which is markedly greater than that of 
other laboratory model organisms (Guryev et al., 2006). In order to overcome this 
inter-animal variation in LPS responsiveness I performed in vitro LPS challenge 
experiments with WKM cells pooled from several animals. 
Whilst other groups have reported LPS induction of tnf expression in embryo 
derived tissues here I did not observe this effect. Watzke et al. report induction of 
expression tnf in embryo tissue stimulated with concentrations as low as 1 ng/ml 
(Watzke et al., 2007). This finding, that cytokine expression in a fish system at 
concentrations comparable with those that activate mammalian systems, disagrees 
with the findings of many research groups that show fish have a higher threshold of 
LPS sensitivity than mammals (Iliev et al., 2005b). Others have demonstrated that 
much higher concentrations of LPS are required in order to induce tnf expression in 
embryos. Induction of expression of tnf was observed on exposure of TNF:GFP 
transgenic embryos to LPS but only at a very high concentration (140µg/ml) 
(Yazawa et al., 2005) which is only 10 µg/ml below the concentration lethal to 
embryos (150 µg/ml)  (Novoa et al., 2009). Oehlers et al. report only a 2 fold 
increase in tnf transcript on exposure of embryo derived intestinal epithelial cells to 
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LPS at 150 µg/ml (Oehlers et al., 2010). In this study, even at the highest 
concentration tested (150 µg/ml), no increase in expression of tnfa was observed in 
the whole embryo. I have shown that LPS can induce a functional effect in embryos, 
enhancement of leukocyte migration, so it is possible that whilst LPS has a localised 
effect on activation of leukocytes, this effect is not detectable in whole embryos 
against the background of other tissues.  
Iliev and colleagues report that the concentration of E. coli LPS required to 
induce expression of tnf in trout macrophages-like cells is 1000 fold higher (1 µg/ml) 
than the concentration required to activate mammalian macrophages. The maximal 
induction of tnf gene expression required concentrations that were orders of 
magnitude higher than the maximal concentration required for activation in 
mammalian systems (>10 µg/ml) (Iliev et al., 2005a). Here I find maximal induction 
of tnf expression by E. coli LPS in zebrafish adult immune cells between 10 and 50 
µg/ml in agreement with the findings of Iliev and colleagues. Consistent with this 
reduced sensitivity to LPS, when compared to mammalian responses, was the finding 
that whilst LPS activated human neutrophils morphologically, at concentrations 
capable of inducing tnf expression in WKM cells, the morphological activation 
phenotype of zebrafish myeloid cells by LPS was absent. These cells were capable of 
morphological activation, confirmed by activating with PMA as a positive control, 
demonstrating another example of lower LPS responsiveness in fish immune cells.  
The inhibitor SB203580 has been shown to inhibit the phosphorylation of p38 
MAPK and this is thought occur by inhibiting the ability of p38 MAPK to 
autophosphorylate (Ge et al., 2002, Ashwell, 2006). Consistent with these findings in 
mammalian studies here zebrafish embryos exposed to SB205803 had reduced levels 
of pp38 when compared with DMSO treated controls, indicating that SB203580 
inhibited the kinase activity of p38 as its ability to autophosphorylate inhibited in 
these embryos at the concentrations used.  
Whilst it is not known which receptor(s) is responsible for LPS recognition in 
fish (Iliev et al., 2005b, Sepulcre et al., 2009, Sullivan et al., 2009) this study and 
others, have shown that LPS is capable of inducing cytokine expression in fish 
leukocytes (Pelegrin et al., 2001, MacKenzie et al., 2003, Iliev et al., 2005a, 
Sepulcre et al., 2009). Sepulcre et al. (2009) also demonstrate activation NF-$B in 
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zebrafish embryos is independent of Myd88. In this study I add further insight into 
the signalling mechanism downstream of this unknown receptor and show that LPS 
induced expression of cytokine is dependent on signalling via p38 MAPK, as it is in 
mammalian systems (Lee et al., 1994). This finding confirms the conserved function 
of p38 MAPK across species as an important mediator of inflammatory signals and 
supports the use of zebrafish as a model organism to study the pharmacological 
effects of inhibition of this protein.  
 
LPS induces expression of chemokines via the action of p38 MAPK 
 
In this study I have analysed the effect of LPS on the inflammatory 
behavioural responses of leukocytes as a population and at the single cell level in 
reaction to acute injury. However whilst this imaging and automated analysis 
approach permits interference in intracellular signalling mechanisms, by the use of 
pharmacological inhibitors, it was not possible to assay gene expression changes 
within the leukocytes, or in the whole embryo, to determine the underlying genetic 
control of the observed changes in inflammatory behaviour. For this reason I used 
adult WKM cells in in vitro stimulation assays to identify genes that are regulated by 
LPS in a p38 MAPK dependent way and therefore find candidate genes that may be 
have a role in the behavioural changes observed. Using this method I have 
demonstrated p38 MAPK to have a conserved role in the mediation of the production 
of inflammatory cytokines. By choosing likely candidate chemokines I have 
demonstrated that zebrafish orthologues of il-8 and cxcl-C1c are induced on 
stimulation with LPS and this induction can be attenuated using an inhibitor of p38 
MAPK activity. LPS is known to induce expression of il-8 in mammalian immune 
cells (Marie et al., 1999, Mukaida, 1992, Harada et al., 1994) and LPS induced 
expression of il-8 is dependent on p38 MAPK signalling in some cell types (Marie et 
al., 1999, Li et al., 2009). Zebrafish il-8 (cxcl8) is expressed on leukocytes and gene 
expression can be induced in epithelial cells by high dose stimulation (150 µg/ml) 
(Oehlers et al., 2010). Here for the first time I have shown that zebrafish il-8 can be 
induced by LPS in a p38 MAPK dependent manner, as it is in mammals. This in 
vitro gene expression data suggests that the regulation of the il-8 and cxcl-C1c might 
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contribute to the complex migratory/behavioural effects mediated by LPS via p38 
MAPK.  
 
This study has shown experimentally that the in vivo migration of leukocytes 
exhibits spatio-temporally structured population heterogeneity. Furthermore, I have 
shown that LPS changes the recruitment, but does not alter in vivo leukocyte 
velocity. The observed effect of inhibiting p38 MAPK has two important 
implications: (i) it indicates that p38 MAPK is only involved in response to LPS (or 
challenge through pathogens) but not injury alone; (ii) it suggests that selectively 
targeting components of immune signalling pathways can change the overall 
behaviour in the leukocyte population. Due to population heterogeneity, I observe 
clear overlap in the chemotactic phenotypes. This heterogeneity, which was herein, 
demonstrated in a whole organism model system, will have clear implications for 
therapeutic interventions which may require attenuation of population heterogeneity 
in addition to a shift in the average behaviour as achieved here.  
 
The novelty of this study lies in the large-scale comparative analysis of the 
characteristics, dynamics and signalling pathway dependency of leukocyte migration 
at the single cell level and the real-time in vivo response to wound injury in the 
presence and absence of endotoxin.  The practical application of these findings lie in 
the potential use of this model to determine the efficacy of candidate therapeutics 
targeting innate immunity in conditions representative of un-stimulated and infected 
wound injury.     
 
In this chapter I describe an in vivo model that uses time-lapse imaging in 
conjunction with a novel automated mathematical method of cell detection to track 
and analyze leukocyte recruitment to damaged tissue. I demonstrate that the number 
and directionality of recruited leukocytes is enhanced by LPS and show that this 
enhancement is dependent on the action of p38 MAPK. 
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CHAPTER 5. Deficiency in Notch signalling impairs 
myelomonocyte development resulting in diminished 
inflammatory responses. 
 




• In this chapter my aim was to investigate the effects of mutations in genes 
within the Notch signalling pathway on inflammatory responses and 
development of the haematopoietic compartment in larval and adult 




Whilst Notch signalling has long been known to influence cell fate and 
differentiation it is only in the last decade that its role in the immunological 
responses of fully differentiated immune cells has begun to be investigated.  There is 
some controversy in the literature over interplay between the Notch and LPS 
mediated signalling. TLR induced responses, including those downstream of the 
LPS/TLR4 receptor complex, are regulated by components of the Notch pathway 
(Hu et al., 2008, Monsalve et al., 2009). LPS treatment has been shown to up-
regulate Notch receptor expression and Notch signalling in macrophages via the 
action of p38 MAPK (Monsalve et al., 2006). Conversely it was recently reported 
that LPS treatment results in the down-regulation of Notch signalling, for example 
down-regulating Notch1 and Hairy enhance of split (Hes1, a well characterised 
transcriptional target of Notch) expression, in mammalian macrophages (Kim et al., 
2008a) and microglial cells (Grandbarbe et al., 2007).  In this study I investigate the 
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effect of LPS treatment on WT and Notch mutant adult zebrafish immune cells in 
order to explore the regulation of LPS responses by components of the Notch 
pathway in an unbiased system, namely one in which mutations in Notch receptors 
and ligands are not directed to a specific cell type. 
Notch signalling is critical in the development of many tissues and its 
contribution to haematopoiesis is now the focus of considerable interest. Notch 
receptors and their ligands are expressed on haematopoietic cells and play a role in 
haematopoietic stem cell (HSC) emergence, self-renewal, differentiation and lineage 
choices (e.g. Cheng et al., 2003). The function of Notch genes in myeloid cell 
differentiation remains controversial with previous studies showing contradictory 
results highlighting the complexity of this pathway in development and 
differentiation. Constitutive expression of Notch1 through retroviral transfection of 
the intracellular domain (NiC) in 32D myeloid progenitors can inhibit granulocytic 
differentiation (Milner et al., 1996). However Schroeder et al (Schroeder et al., 
2003) showed that transient activation of Notch1 signalling reduced the self renewal 
of multipotent progenitor cells and increased differentiation of granulocytes, 
macrophages and dendritic cell (DC) lineages through a direct increase in PU.1, a 
transcription factor involved in myeloid proliferation. Retroviral transduction of NiC 
in RAG-/- mouse derived BM cells resulted in enhanced renewal of HSC, which 
favoured lymphoid as opposed to the myeloid lineage (Stier et al., 2002). In contrast 
it was reported that transient Notch activation in irradiated adult zebrafish 
accelerated repopulation of all lineages without any skewing for lymphoid or 
myeloid lineage (Burns et al., 2005). Notch deficiency in hematopoietic progenitor 
cells and Notch1 -/- embryonic stem cells resulted in impaired development of 
myeloid and lymphoid DCs in the mouse (Cheng et al., 2003). Conditional deletion 
of Mindbomb in the mouse induced increased numbers of granulocyte progenitors 
leading to myeloproliferative disease (Kim et al., 2008b) whereas in zebrafish, 
Mindbomb mutants analysed at 28 hpf revealed no differences in the numbers of 
cells expressing the myeloid markers PU.1, MPO and L-plastin as compared to wild 
type (WT) (Burns et al., 2005). 
Several zebrafish lines exist with mutations in genes encoding components of 
the Notch pathway. These mutants were identified from a large-scale ENU screen for 
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zygotic mutations that affected the embryonic development in zebrafish (Haffter et 
al., 1996). Mutations in four Notch pathway related genes all resulted in abnormal 
somatogenesis (van Eeden et al., 1996, Julich et al., 2005). Two such mutants are 
beamter (BEA) and deadly seven (DES) that carry mutations in delta C and notch 1a 
genes respectively (Julich et al., 2005, Holley et al., 2002). These mutant zebrafish 
have developmental defects but are viable, probably due to gene duplication. The 
defects caused by the mutation in the Notch1a gene, characterised so far, include, 
perturbed motor axon outgrowth, neurogenesis, and somitogenesis (Gray et al., 
2001). Genetic manipulation of the Notch pathway in the mouse is hampered by the 
fact that in most cases the knockout of genes involved in this pathway is embryo 
lethal restricting this approach to conditional cell specific targeting of mutations. The 
availability of viable mutant zebrafish lines with defects in the Notch pathway 
provides a novel tool to investigate the function of this pathway in inflammatory 
responses and haematopoiesis.  
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Results 
LPS mediated suppression of hes1 gene expression is absent in DES 
mutant WKM cells.  
 
In this study I have demonstrated that LPS induces cytokine and chemokine 
expression in zebrafish WKM cells. Since it is has been reported that LPS 
stimulation of immune cells can result in suppression of signalling in the Notch 
pathway, I aimed to determine whether or not, as in some mammalian cell types, 
LPS would suppress Notch target genes in zebrafish immune cells. LPS stimulation 
of WKM cells in WT fish resulted in repression of the expression of hes1 in a dose 
dependent manner. The highest suppression (50% when compared to the 
unstimulated sample) was observed at the highest concentration of LPS (10 µg/ml) 
(Figure 29 A). This suppression of hes1 expression by LPS stimulation was not 
observed in WKM cells derived from DES mutants that have a mutation in the 
Notch1a gene (Figure 29 B). Inhibition of hes1 specific transcripts was observed in 
the cells derived from WKM of BEA mutants (30% when compared to the 
unstimulated sample) at the highest concentration of LPS only (10 µg/ml), however 
this reduction in expression was not as marked as that observed in the WT (Figure 29 
C).  
 
Functional effects of mutations in the Notch pathway in zebrafish 
embryos  
 
Since it is known that Notch has roles in the inflammatory response and 
myelopoiesis it seemed possible that zebrafish embryos with mutations in genes in 
the Notch pathway might display defects in recruitment of cells to a site of acute 
inflammation. In order to test this hypothesis I compared the number of neutrophils 
that were recruited in tail transection injury in WT and Notch mutant embryos. A 
significantly lower number of neutrophils were recruited to the wound site in BEA 
(10 cells vs. 8 cells, P<0.05) and this was more marked in the DES mutants (10 cells 
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vs. 4 cells, P<0.001) (Figure 30). While this experiment demonstrates that there is 
indeed a reduction in the number of neutrophils recruited to acute injury in Notch 
mutant embryos it does not identify the mechanism(s) that underlie the defect. This 
reduction could be due to a Notch mutation mediated defect in myelopoiesis with 
fewer neutrophils developing in the embryo resulting in fewer neutrophils available 
for recruitment, or a functional defect restricting the ability of the neutrophils to 
migrate towards the wound or a combination of both. 
To assess whether the low recruitment in the mutants was due to an impaired 
migratory function of these cells in the absence of Notch signalling WT embryos 
were treated with the #-secretase inhibitor, DAPT (50 µM), which is effective in 
inhibiting Notch signalling in zebrafish embryos at this concentration (Geling et al., 
2002). Inhibiting Notch signalling shortly before and throughout the acute neutrophil 
response did not affect the number of cells migrating to the wound site in WT fish 
(Figure 31 A). Confirmation that DAPT treatment was effective was obtained by 
demonstrating that hes1 mRNA was reduced in treated embryos as compared to 
untreated fish or DMSO vehicle treated controls (Figure 31 B).  
In order to further confirm that defects in Notch pathway signalling is 
correlated with a reduction in neutrophil recruitment expression of the Notch target 
gene zebrafish hes1 expression was determined in WT, BEA and DES embryo 
derived tissue samples. Expression of hes1 in embryonic tissue was significantly 
lower (P<0.01) in DES mutants when compared with WT tissue (Figure 32). BEA 
embryo tissue had comparable levels of expression with WT tissue (Figure 32).  
 
Deficiencies in Notch signalling impairs myelomonocyte development  
 
Defects in recruitment of neutrophils to acute injury in BEA and DES 
embryos was not mimicked using the Notch signalling inhibitor DAPT.  This 
observation suggests that there may be a developmental defect in haematopoiesis in 
the myeloid compartment and to investigate this possibility flow cytometry was 
performed on WKM immune cells derived from adult WT and mutant zebrafish.  
Results of the flow cytometry experiments performed on 2-3 month old adult mutant 
and WT fish using cells from the WKM (Figure 33 A) showed that the percentage of 
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myelomonocytes was significantly lower in Notch mutants BEA (p<0.001) and DES 
(p<0.01) compared to WT while percentages of lymphocytic cells were higher in 
mutants (BEA (p<0.01) and DES (p<0.01) vs. WT) (Figure 33 B and C). The 
percentage of precursor cells was similar in all groups (Figure 33 D). The total 
number of cells collected from WKM was similar in all fish indicating that Notch 
mutants have lower overall numbers of myelomonocytes than WT fish. 
This trend was reflected in the periphery with a significantly lower 
percentage of granulocytic cells in the coelomic cavity of mutants when compared 
with WT (BEA (p<0.05) and DES (p<0.01) vs. WT) (Figure 34 B). Again the 
lymphocyte containing populations showed higher percentages in mutants compared 
with WT (BEA (p<0.05) and DES (p<0.05) while no significant differences were 
observed in the nonspecific cytotoxic cells (NCCs) described by Moss et al (Figure 
34 C & D). 
 
Defect in myelopoiesis has no effect on survival in M. marinum 
infection experiments 
 
Here I report that mutations in zebrafish notch1a and deltaC genes results in 
the development of fewer myeloid cells in adult and embryo. To further explore the 
potential differences in host cellular innate responses in the Notch mutant WT and 
DES embryos (which showed the strongest reduction in neutrophil recruitment 
phenotype in the embryo injury model) were infected with M. marinum. DES 
embryos were chosen as they showed highest differences in cell proportions when 
compared to WT. Survival time in response to bacterial challenge was equivalent 
between WT and DES embryos (Figure 35).  
 
 




Figure 29. Quantitative PCR analysis of expression of zebrafish hes1 expression in 
adult WT (A), DES (B) & BEA (C) WKM tissue. Stimulation with various 
concentrations of LPS (serotype 055:B5) was performed on pooled WKM cells 
extracted from adult fish and the tissues processed for cDNA. Gene expression is 
normalised to 18S and is presented as relative to the mean of the unstimulated 
sample, results of 1 experiment representative of & 3 performed. 
 




Figure 30. Reduced recruitment of MPO stained cells to a tail transection wound 
injury in 5dpf BEA and DES mutant embryos compared to WT (A). 5 dpf zebrafish 
embryos were submitted to a tail transection and after 4 hours stained for MPO. 
MPO positive cells recruited to the wound site were counted and groups compared as 
follows, WT (light grey bars), BEA (dark grey bars) and DES (black bars). (D). The 
data presented are representative of at least 3 experiments. 
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Figure 31.  5 dpf WT embryos were treated with DAPT (50 µM) or with equivalent 
levels of DMSO control for 4 hours prior to being submitted to a tail transection. 
After 4 hours fish were fixed and stained for MPO. MPO positive cells recruited to 
the wound site were counted and groups compared as follow, DMSO (white bars), 
DAPT (light grey bars) (A). WT embryos were collected following DAPT and 
DMSO treatment and RNA extracted for analysis of Hes1 mRNA levels by TaqMan 
RT- PCR, results were normalised to 18S and relative expression compared to 
untreated controls (B). The experiments shown are representative of at least 3 
performed. 
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Figure 32. Quantitative PCR analysis of expression of zebrafish hes1 expression in 
WT and Notch mutant embryo tissue (4 & 5 dpf). RNA lysates from WT fish (white 
bar), BEA (grey bar) and DES mutant fish (black bar) and processed for cDNA. 
Gene expression is normalised to 18S and is presented as relative to the mean of the 
unstimulated WT sample. Bars represent mean expression from 5 separate pooled 
samples. Embryo tissue lysates were produced with >30 embryos in each pool. 
 




Figure 33. Leukocyte proportions in WKM are affected in Notch mutants. Cells 
isolated from WKM of WT, BEA and DES mutants were obtained from adult 
zebrafish and analysed using flow cytometry based on their forward and side scatter 
characteristics. A typical profile of live cells obtained for WKM (A). The gates used 
for the analysis of various cell populations were as follow  R2= myeolomonocytes, 
R3= precursors and R4 lymphocytes. Percentage of gated cells were plotted for each 
fish (B-D). Data are presented with line at mean and analysed using one-way 
variance analysis (ANOVA) test with Bonferroni's Multiple Comparison. 
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Figure 34.  Leukocyte proportions in coelomic cavity are affected in Notch mutants. 
Cells isolated from CC of WT, BEA and DES mutants were obtained from adult 
zebrafish and analysed using flow cytometry based on their forward and side scatter 
characteristics. A  shows a typical profile of live cells obtained for CC. The gates 
used for the analysis of various cell populations were as follows R5=granulocytes, 
R6=lymphocytes, R7=NCC for Coelomic cavity. Percentage of gated cells were 
plotted for each fish (C-E in WKM and F-G in CC). Data are presented with line at 
mean and analysed using one-way variance analysis (ANOVA) test with 
Bonferroni's Multiple Comparison. 
 
 
   133 
 
 
Figure 35. Survival following infection with M. marinum is unaffected in Notch 
mutant embryos. WT and DES mutant embryos (over 50 in each group) were 
injected at 28 hpf with dsRed M. marinum. Survival was monitored daily and 
survival curves are shown for each groups. The experiments shown are 
representative of at least 3 performed. 
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Discussion 
 
LPS mediated suppression of hes1 gene expression is absent in DES 
mutant WKM cells.  
 
There is controversy regarding the effect of LPS on the expression of Hes1, a 
gene transcriptionally regulated by Notch signalling. Several research groups have 
reported LPS activation of various cell types resulted in increased Notch1 
transcription and protein levels (Li et al., 2001, Monsalve et al., 2006, Monsalve et 
al., 2009). This upregulation of Notch might be expected to result in the subsequent 
upregulation of Hes1, a target gene of Notch signalling. Indeed it has been described 
that Hes1 expression increased in response to LPS exposure in a macrophage cell 
line (Palaga et al., 2008) and in human primary human macrophages (Hu et al., 
2008). In contrast Kim et al. showed Hes1 protein and mRNA gene expression levels 
were suppressed after LPS exposure via the Notch signalling pathway in the same 
human macrophage cell line used by Palaga and colleagues (Kim et al., 2008a, 
Palaga et al., 2008). It was also found that LPS treatment of primary rat microglial 
cells resulted in downregulation of the expression of Hes1 (Grandbarbe et al., 2007). 
Here I show zebrafish hes1 gene expression is suppressed in a dose dependent 
manner in adult zebrafish immune cells, which would support the studies that 
identify LPS as a suppressor of Hes1 expression. This suppression was absent in 
WKM cells derived from adult DES (Notch1a) mutant fish which confirms the LPS 
induced hes1 suppression in zebrafish immune cell responses is Notch dependent. 
The weaker suppression of hes1 expression observed in the BEA fish can be 
explained by the fact that these fish have a mutation in only one ligand of the Notch 
ligand family, of which there are several, and so a compensatory mechanism 
involving the remaining functioning ligands may counter balance the effect of the 
loss of function of single ligand. Results from our laboratory show that bone marrow 
derived dendritic cells (BMDCs) stimulated with a combination of LPS and Jagged 
respond with a downregulation of Hes1 gene expression (Bugeon et al., 2008 and 
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personal communication with Dr M Gentle). This finding would also support the 
published studies that reveal LPS to be a suppressor of Hes1 expression.  
 
Functional effects of mutations in the Notch pathway in zebrafish  
 
Here I have shown BEA and DES zebrafish with mutations in Notch pathway 
gene exhibit defects in myelopoiesis from an early stage of development and into 
adulthood. BEA fish with mutations in the DeltaC gene displayed a weaker 
phenotype that the DES fish, which have mutations in the Notch1a gene. For 
example injury recruitment, suppression of expression of hes1, and the proportion of 
granulocytes in the coelomic cavity were more pronounced phenotypes in the DES 
mutants. This is perhaps explained by the fact that the mutation in the DES fish is in 
receptor whereas the BEA mutants have defects in the ligand for the receptor. DeltaC 
is one of four known members of the Delta family in zebrafish (Haddon et al., 1998). 
It is likely that there is some compensation for the defects in DeltaC from alternate 
Notch ligands that would explain the weaker phenotype observed in the BEA than 
the DES (Notch1a) mutants. The defects in myelopoiesis, caused by disruption of 
Notch signalling, presented here are consistent with the results of Cheng et al. 
(Cheng et al., 2003) who demonstrated that Notch1 deficient ES cells or HPCs had 
reduced ability to differentiate into myeloid cells. They also support the findings of 
Schroeder and colleagues who found an increased and accelerated differentiation 
along the myeloid lineage following co-culture of haematopoietic progenitors with 
Notch ligand expressing cells (Schroeder et al., 2003). The ability of Notch 
signalling to enhance myelopoiesis was highlighted recently by Delaney and 
colleagues in phase 1 clinical trials where substantially enhanced rates of myeloid 
engraftment were found following conditioning of cord blood cells with Delta-like1 
ligands before transplantation (Delaney et al., 2010).The data presented here 
supports a role for Notch in maturation of myeloid cells, which is in agreement with 
the findings of Cheng et al., and others, however they have also shown that Notch 
signalling prevents maturation of immature precursors into mature dendritic cells. In 
the analysis of WKM cells I failed to observe an increase in the relative numbers of 
precursors in the Notch mutants. Whilst there was no observed increase in precursor 
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numbers between WT and Notch mutants, there was a shift towards the lymphocyte 
lineage in both BEA and DES mutants. There were significantly higher numbers of 
lymphocytes in the Notch mutant samples than the WT.  
Whilst some studies do show a requirement for Notch signalling in the 
maturation of myeloid cells several studies also present evidence that Notch 
signalling is required for the maturation of lymphocytes. Stier et al. demonstrate 
Notch1 induced preferential commitment of stem cells to a lymphoid rather than a 
myeloid lineage, which is in opposition with the findings of this study that a 
mutation in Notch1 results in preferential development of lymphocytes over myeloid 
cells (Stier et al., 2002). Notch plays an important role in the differentiation and 
maturation of T-cells (reviewed by (Radtke et al., 2010). In fact Notch signalling 
must be tightly regulated and suppressed within the bone marrow in order to prevent 
ectopic differentiation of T-cells in the bone marrow (Maeda et al., 2007). Several 
research groups have found that interrupted canonical Notch1 signalling results in 
inhibition of many cell fate potentials including B-cell and myeloid cell types 
(reviewed in Radkte et al., 2010). Given that Notch1 signalling can promote the 
differentiation of T-cells in preference to other cell types does not necessarily 
disagree with the findings of this study. Here I show mutations in Notch related 
genes result in the higher proportions of lymphocytes in the WKM. The lymphocyte 
gate is made up of T-cells and B-cells and therefore it is possible that the impaired 
signalling in the Notch pathway resulting from the mutations has impaired T-cell 
differentiation but enchanced B-cell differentiation resulting in greater numbers of 
lymphocytes overall. 
The role played by Notch signalling in cell fate commitments in 
haematopoiesis is a complex and controversial area of research. The data presented 
here contributes to this debate and supports Notch signalling as a promoter of the 
differentiation of the myeloid cell lineage above the lymphoid.  
 




   137 
Since it has been shown that macrophages play a key role in dissemination 
and disease progression in mycobacterial infections in zebrafish embryos (Davis et 
al., 2002a, Clay et al., 2007) I investigated whether or not DES mutant embryos, 
which have fewer myeloid cells than WT, had altered survival rates in response to 
mycobacterial infection. Studies in mouse have shown that macrophage depletion 
during mycobacterial infection results in improved clinical outcome (Leemans et al., 
2001, Leemans et al., 2005) however depletion of macrophages in zebrafish embryos 
resulted in higher bacterial burdens (Clay et al., 2007). In light of these studies some 
alteration in the rate of mortality between WT and Notch mutant embryos might 
have been expected. However the reduction in myeloid cells in DES embryos had no 
effect on survival rates of embryos infected with M. marinum. The level of reduction 
of myeloid cell number in DES embryos was 40% (as assayed by neutrophil 
response to tail transection) and so 60% of the cells in the myeloid compartment 
were available for response to infection. This reduction, but not complete depletion, 
of myeloid cells may explain the absence of an observed effect on survival by the 
Notch1a mutation in the DES fish versus the WT. In a mouse study of mycobacterial 
infection/macrophage depletion in lung, in which clinical effect of macrophage 
depletion was observed, 80% depletion of macrophages was achieved (Leemans et 
al., 2001). Similarly complete depletion of macrophages was achieved in zebrafish 
mycobacterial infection experiments that resulted in altered disease outcomes (Clay 
et al., 2007). Perhaps here the partial reduction in myeloid cell numbers was not 
sufficient to cause an alteration in disease phenotype in this infection model, with the 
remaining macrophages able to compensate for the overall reduction in number.  
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CHAPTER 6 – FINAL DISCUSSION AND FUTURE WORK 
 
 In this thesis I have extended and characterised existing zebrafish models of 
inflammation in order to facilitate analysis of host responses to inflammatory signals 
that differ both quantitatively and qualitatively.  Applying these experimental models 
I have investigated the inhibitory effects of p38 MAPK on different aspects of 
leukocyte biology, namely transcriptional and migratory responses in zebrafish 
embryos in vivo following wound injury alone and combined with exposure to LPS. 
The results revealed that only the LPS effect on leukocyte recruitment was p38 
MAPK dependent. Also from the analysis of gene expression profiles of 
inflammatory cells isolated from adult zebrafish I observed that LPS mediated 
responses are comparable to those reported for mammalian systems. Therefore, in 
this respect zebrafish mimic mammalian innate responses and may be adapted to 
provide a high throughput screen to test the anti-inflammatory effects of small 
molecule inhibitors. 
Zebrafish are genetically tractable and their larvae are transparent organisms 
which has facilitated the development of a novel automated computational single cell 
tracking and analysis system. This system I have applied in defining the 
heterogeneity of leukocyte migration to different inflammatory signals. Biological 
systems available for exploring the dynamical behaviour of leukocytes in real-time 
and in response to immune modulators are limited and the system I have reported 
here fulfils both both of these criteria. In vivo single cell tracking is still a relatively 
new and expanding area of biological research. Currently it is possible to track 
immune migration and cell-interactions in live mouse models.  For example using 
explanted lymph node tissue (Stoll et al., 2002), exteriorised cremaster muscle 
(Dunne et al., 2004), and by studying inflammatory cellular responses in the iris 
which is relatively visually accessible (Rosenbaum et al., 2008). Zebrafish, however, 
have several advantages over existing mammalian in vivo leukocyte tracking 
systems, notably the small size of the zebrafish embryo tail makes it is possible to 
have the entire region from the transection wound up to the vasculature in the fields 
of view which means all cells recruited to the wound can be visualised and tracked. 
Secondly immobilisation of the larvae in agar negates problems caused by 
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movements such as breathing and eye movements which will affect the mammalian 
models. While imaging in zebrafish embryos is ideal for studying innate immune cell 
interactions the lack of an adaptive immune system at this early stage of 
development prevents analysis of cell interactions between the innate and adaptive 
immune systems.  However, the availability of transparent zebrafish lines (White et 
al., 2008) may allow imaging to be developed for the analysis of these more complex 
cellular interactions.  
 The automated cell tracking system was developed and validated using the 
effect of LPS on basal leukocyte migration and its sensitivity to p38 MAPK 
inhibitors as an experimental model. Indeed I was able to detect and quantify the 
effect of behavioural changes in the dynamic cell recruitment in response to 
exogenous inflammatory signals. The application of the tracking system in an intact 
organism allows microenvironments, such as a H2O2 gradient on cell migration to 
exert their physiological effects on cell migration which would be difficult to 
establish for in vitro models. In addition to validating a novel experimental system 
the results of these experiments have also extended existing knowledge on LPS 
effects on the dynamics of the migration of single cells gained largely from in vitro 
cell culture studies. The practical application of this study lies in the potential use of 
this model to determine the efficacy of candidate therapeutics targeting innate 
immunity in conditions representative of unmodified and infected wound injury. 
 In light of the potential application of p38 MAPK inhibitors as therapeutic 
agents for inflammatory diseases such as RA and IBD the primary aim of my thesis 
was to investigate the mode of action of this class of compounds in vivo on the innate 
immune system. To this end I have demonstrated that p38 MAPK blocks LPS 
induced leukocyte migration but not that observed following wound injury alone.  
However, p38 MAPK inhibitors have so far yielded disappointing results in clinical 
trials designed to evaluate their anti-inflammatory effects. It is thought that a 
compensatory mechanism abolishes the initial anti-inflammatory effect that occurs in 
vivo and this undoubtedly will involve a combination of innate and adaptive 
immunity. There is hope however that using less selective inhibitors or targeting 
kinases higher up the signalling cascade might prove successful alternative 
strategies. Potential reasons for the unforeseen failure of inhibition of p38 MAPK 
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inhibitors as therapeutics include dosage limitations (although the more recent 
compounds do reach therapeutic concentration without toxic effects), bio-distribution 
(alteration in the liphophilicity of newer drugs to prevent CNS presentation has the 
potential to limit the efficacy of the compounds), and as p38! is now known to 
regulate anti-inflammatory processes (e.g. IL-10 production) the potential anti-
inflammatory benefits of inhibition may be counterbalanced (Hammaker and 
Firestein, 2010). The redundant nature of signalling cascades means that it is likely 
that effect of the inhibition of one downstream kinase will be compensated by 
kinases upstream (Hammaker and Firestein, 2010). It is now thought that this might 
be overcome by targeting multiple kinases higher up in the signalling cascade and 
the proposed targets are tyrosine kinases including the Janus kinases (JAKs) and 
spleen tyrosine kinases (Syks). Inhibitors of the JAKs and Syks have been tested in 
clinical trials and show excellent efficacy in treatment of patients with RA 
(Hammaker and Firestein, 2010). The cell tracking system presented here provides 
an in vivo screening system for other potential small molecule anti-inflammatory 
inhibitors and can be used to test the capacity of new alternative strategies to 
modulate the behaviour of recruited leukocytes.  
 I investigate leukocyte migration and transcriptional responses in Notch null 
mutant zebrafish and the results of that analysis confirm other studies that have 
demonstrated that Notch signalling contributes to the regulation of haematopoiesis 
and immune responses. The key role played by Notch in cell fate decisions in the 
bone marrow and its expression in a wide range of tissues restricts consideration of 
this pathway as a target for the therapeutic modulation of immune responses. 
However due to its association with the development of some forms of blood cell 
cancers including leukaemia, for example over 55% of paediatric primary T-ALL 
tumours tested in one study had at least one mutation in the NOTCH1 gene (Weng et 
al., 2004, Radtke et al., 2010) the Notch signalling pathway is being explored as a 
potential therapeutic target for the treatment of some types of leukaemia. Mutations 
that induce greater strength of Notch signalling cooperate with other oncogenic hits 
and influence tumorigenesis (Radtke et al., 2010). The current strategy for targeting 
inhibition of the Notch pathway in clinical trials is to use #-secretase inhibitors which 
non-selectively target all Notch receptors. So far #-secretase inhibitors have proven 
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weakly effective against human T-ALL leukaemia in humans and have unwanted 
side effects including gastrointestinal toxicity (Milano et al., 2004). New small 
molecule inhibitors that block signalling in the Notch pathway are being developed 
and early studies indicate some success in blocking the proliferation of leukemic 
cells in vitro. This study has demonstrated that in zebrafish, as in mammals Notch 
signalling directs cell fate decisions and haematopoiesis. Existing zebrafish models 
of cancer include models of T-ALL leukaemia (Langenau et al., 2003, Langenau et 
al., 2005), and could be used to screen the effectiveness of new small molecule for 
therapeutic effect.   
In this thesis I have demonstrated the value of zebrafish to study mammalian 
immune responses and derived new information on the dynamics of leukocyte 
recruitment/retention at sites of inflammation.  This model organism through its 
advantages in facilitating optical imaging and genetic tractability I am sure will 
continue to aid in advancing our knowledge of mammalian biology and human 




There are many directions in which I could expand the results I have described here: 
1. An initial extension would be to select other pathway inhibitors and screen 
their effects on leukocyte migration to wound injury in the presence and 
absence of other inflammatory signals including LPS. 
2. It would be informative to investigate the effect of altering chemoattractant 
gradients such as H2O2 (Niethammer et al., 2009) on the dynamics of 
leukocyte migration in responses to qualitatively different inflammatory 
signals.  
3. The automated single cell tracking system developed and described in this 
study currently permits the interpretation of the dynamic behaviour of single 
cells. I would like to extend the remit of the system to include the 
transcriptional profile of cells displaying different dynamic behaviour. The 
gene expression profiling of tracked immune cells could be achieved by the 
laser dissection and trascriptome profiling of single cells whose dynamical 
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movement has been previously recorded. This would allow the transcriptional 
profile of cells to be correlated with their dynamic behaviour and furthermore 
heterogeneity of behaviour could begin to be associated with specific patterns 
of gene expression.  
4. This in vivo cell tracking system could also be expanded to include the 
interactions of host immune cells with invading pathogens. The recruitment 
of cells to sites of inflammation that contain fluorescently labelled pathogens 
would enable the dynamic behaviour of immune cells in the context of live 
infection to be visualised and analysed. It would also be possible to measure 
changes in leukocyte migratory behaviour following the phagocytosis of 
bacteria.  
5. It may be possible to adapt the cell tracking system to transparent adult 
zebrafish to investigate more complex cell interactions between the innate 
and adaptive immune systems. 
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